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CHAPTER ONE:  
 
INTRODUCTION 
 
Swallowing and cough are two vital functions that are reflexive in nature and are related to 
each other in terms of shared neural and anatomical space. When a disorder impacts normal and 
effective swallowing and/or cough, the consequences can be life-threatening. Evaluation and 
treatment of swallowing and cough disorders can fall under the scope of practice of the speech-
language pathologist and speech-language pathologists often are leading professionals.  
Furthermore, much of the current research on swallowing and cough is spearheaded by speech-
language pathologists often working with a multi-disciplinary team. The focus of this dissertation 
is on the clinical evaluation of cough and swallowing, practice patterns of voluntary cough 
assessment during the evaluation of swallowing, and novel methods of evaluating acoustic 
voluntary cough waveforms in patients with and without swallowing impairment. The results will 
provide important information regarding the state of cough assessment tools for clinical 
swallowing evaluation, clinical practice patterns of voluntary cough assessment, and differences 
in acoustic cough signals between safe and unsafe swallowers in individuals with Amyotrophic 
Lateral Sclerosis (ALS).  
It is important to understand the basic terminology, physiology, and neurophysiology of 
swallow and cough in order to frame and interpret the studies included in this dissertation. This 
introduction is designed to provide the background and motivation for the subsequent 
investigations. Swallowing is a complex sensory and motor function; it is described by its clinical 
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characteristics such as coughing and choking while eating or drinking. Dysphagia is the term that 
denotes disordered swallowing (Logemann, 1984). Unidentified or untreated dysphagia may lead 
to a pulmonary infection termed, aspiration pneumonia (Ebihara, 2016). Evaluation of swallowing 
function is performed on a continuum. Swallowing screening implies a pass/fail criteria, clinical 
swallowing evaluation (CSE) is a more in depth evaluation of swallowing, and finally, the 
modified barium swallow (MBS) study is considered the gold standard instrumental assessment 
of swallowing ability. The Penetration Aspiration Scale (PAS) often is used during gold standard 
swallowing assessment to rate swallowing function and denote level of airway compromise and 
the patient’s ability to successfully eject material from the airway (Rosenbek, Robbins, Roecker, 
Coyle, & Wood, 1996).  
Cough and swallowing are intricately related. Physiologically, cough consists of “an 
inspiratory effort (inspiratory phase), followed by a forced expiratory effort against a closed glottis 
(compressive phase) followed by opening of the glottis and rapid expiratory airflow (expulsive 
phase)” (Widdicombe & Fontana 2006, p. 10). Clinically, the cough is a respiratory event that 
serves to maintain ventilation by protecting the lower airways (West 1995). Cough, a vital airway 
protective mechanism, is particularly important for those with disordered swallowing. Dystussia, 
or disordered cough is a key clinical feature of dysphagia and described by its clinical features. 
Physiologically, dystussia reduces a patient’s ability to protect his/her airway. And clinically, 
dystussia decreases an individual’s ability to protect their airway and thus greatly increases the 
risk for aspiration, subsequent aspiration pneumonia, and excess hospitalizations (Ebihara, 2016; 
Hegland, Okun, & Troche, 2014; Pitts, Bolser, Rosenbek, Troche, & Sapienza, 2008; Plowman, 
Watts, Robison, Tabor, Dion, Gaziano, Vu, & Gooch, 2016; Smith Hammond, 2001). 
Although the MBS provides good visualization of a patient’s ability to protect the airway 
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and direct visualization of cough effectiveness, it is not always performed. The CSE is often 
implemented in place of, or prior to an MBS and is a critical component of the swallowing 
evaluation but fails to identify all those with unsafe swallowing especially those who do not 
respond to deep penetration or aspiration with a cough. Therefore, clinicians rely on clinical signs 
and symptoms to detect dysphagia or dystussia.  
Respiratory, cough, and swallowing impairments are highly prevalent in individuals with 
neuromuscular diseases such as Amyotrophic Lateral Sclerosis (ALS) and Parkinson’s disease 
(PD).1Dystussia has been described in neurodegenerative disease populations such as PD, Stroke, 
and ALS (Pitts, Bolser, Rosenbek, Troche, & Sapienza, 2008; Plowman, Watts, Robison, Tabor, 
Dion, Gaziano, Vu, & Gooch, 2016; Smith Hammond, 2001) by using gold standard physiologic 
analysis of airflow waveforms called cough spirometry. Although it appears that voluntary cough 
production is related to airway protection status during swallowing in several patient populations, 
the gold standard methodology to test cough objectively is costly, the analysis labor intensive and 
time consuming, and requires extensive training to perform expert evaluation of physiologic cough 
waveforms. Given the limitations for the application of gold standard cough assessment, clinicians 
may not have the necessary tools to correctly detect impaired cough. Cough evaluation may 
therefore be under-utilized while evaluating dysphagia symptoms. While current clinical 
                                                 
1 (Ali, Wallace, Schwartz, Decarle, Zagami, & Cook, 1996; Benditt & Boitano, 2013; 
Bogaard, Hovestadt, Meerwaldt, Vd Meche, & Stigt, 1989; Brown, 1994; Bushmann, Dobmeyer, 
Leeker, & Perlmutter, 1989; Coates & Bakheit, 1997; De Bruin, De Bruin, Lees, & Pride, 1993; 
Ebihara, Saito, Kanda, Nakajoh, Takahashi, Arai, & Sasaki, 2003; Fontana, Pantaleo, Lavorini, 
Benvenuti, & Gangemi, 1998; Gross, Mahlmann, & Grayhack, 2003; Hegland, Okun, & Troche, 
2014; Hunter, Crameri, Austin, Woodward, & Hughes, 1997; Miller, Noble, Jones, & Burn, 2006; 
Nagaya, Kachi, Yamada, & Igata, 1998; Pitts, Bolser, Rosenbek, Troche, & Sapienza, 2008; 
Saleem, 2005; Sathyaprabha, Kapavarapu, Pall, Thennarasu, & Raju, 2005; Troche, Okun, 
Rosenbek, Musson, Fernandez, Rodriguez, Romrell, Pitts, Wheeler-Hegland, & Sapienza, 2010; 
Troche, Brandimore, Godoy, & Hegland, 2014; Troche, Huebner, Rosenbek, Okun, & Sapienza, 
2011; Tzelepis, Mccool, Friedman, & Hoppin Jr, 1988). 
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evaluation of cough is focused on cough frequency, cough reflex testing (often using tussive 
agents), voluntary cough measures, and patient subjective ratings of severity, little is known 
regarding the reliability or validity of clinician perceptions of voluntary cough effectiveness or the 
acoustic characteristics of cough during the clinical swallow evaluation. A recent study 
investigated the perceptual features of cough (Laciuga, Brandimore, Troche, & Hegland, 2016), 
and found that coughs with specific perceptual features also shared airflow characteristics. 
However, further work is warranted to determine specific disordered features of impaired cough 
that relate to airway protection in multiple patient populations. Currently, there is little information 
on the clinical use of perceptual cough ratings and there are no validated screening tools that 
support clinician rating of cough impairment or that are designed to determine the relation of such 
ratings to airway protection during swallowing. There remains a clinical need for a cost effective, 
readily available, low technology, sensitive and specific clinical screening tool of voluntary cough 
that may aide in determining an individual’s risk for aspiration during swallowing.  
Eupnea/Breathing 
All mammals engage in breathing behaviors. In humans, the transition from a breathing 
state to swallowing is an essential life sustaining behavior.2 The processes of breathing, 
swallowing, and coughing (airway protection) are interrelated at both neurological and 
physiological levels (Gestreau, Milano, Bianchi, & Grelot, 1996; Pitts, Rose, Mortensen, Poliacek, 
                                                 
2 (Feroah, Forster, Fuentes, Lang, Beste, Martino, Pan, & Rice, 2002; Gross, Atwood, Ross, 
Eichhorn, Olszewski, & Doyle, 2008; Hadjikoutis, Pickersgill, Dawson, & Wiles, 2000; Kelly, 
Drinnan, & Leslie, 2007; Pitts, Morris, Segers, Poliacek, Rose, Lindsey, Davenport, Howland, & 
Bolser, 2016; Pitts, Rose, Mortensen, Poliacek, Sapienza, Lindsey, Morris, Davenport, & Bolser, 
2013b; Preiksaitis & Mills, 1996; Stanford, Galvin, & Rooholamini, 1988; Terzi, Orlikowski, 
Aegerter, Lejaille, Ruquet, Zalcman, Fermanian, Raphael, & Lofaso, 2006; Wilson, Thach, 
Brouillette, & Abu-Osba, 1981) 
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Sapienza, Lindsey, Morris, Davenport, & Bolser, 2013b; Troche, Brandimore, Godoy, & Hegland, 
2014). Quick adaptation from one behavior to another allows for normal airway protection. It is 
essential to understand the neuroanatomical function of normal breathing including lung function, 
swallowing, and coughing in order to identify a disordered state. Eupnea (i.e. quiet breathing) is a 
rhythmic respiratory pattern to move air for ventilation and gas exchange (Bautista, 2014; Bianchi, 
Denavit-Saubie, & Champagnat, 1995; Bolton, Chen, Wijdicks, & Zifko, 2004; Bonham, 1995; 
Champagnat, 2003; Clark & Von Euler, 1972; Gray, Janczewski, Mellen, Mccrimmon, & 
Feldman, 2001; Von Euler, 1986; Wang, 1964; West, 1995) Eupnea can be divided into three 
phases: 1) inspiration; 2) post-inspiration (i.e. early expiration); and 3) expiration (Bianchi, 1995; 
Richter, 1982; Richter, 1986). The lungs do not have an internal mechanism to produce the 
rhythmic pattern that characterizes eupnea. As such, eupnea is centrally mediated. 
Breathing is controlled via brainstem pathways. The motor neurons that drive respiratory 
muscles are divided into three groups: 1) sub-nucleus of the nucleus tractus solitaries (NTS) and 
the dorsal respiratory group (DRG) in caudal dorsomedial medulla; 2) ventral respiratory group in 
ventrolateral medulla (VRG); and 3) pontine respiratory group (PRG) in dorsolateral pons (Abdala, 
Rybak, Smith, & Paton, 2009; Ellenberger & Feldman, 1988, 1990). The Raphe and retro-
trapezoidal nucleus (RTN/PF) (which overlaps with the para-facial respiratory group) also play a 
role in the activation of inspiratory and expiratory driven neurons (Connelly, Ellenberger, & 
Feldman, 1989). Dorsal inspiratory neurons have monosynaptic connection with contralateral 
phrenic motoneurons (Averill, Cameron, & Berger, 1985; Cohen, 1974). The basic breathing 
rhythm originates in the ventral reparatory group (Smith, Ellenberger, Ballanyi, Richter, & 
Feldman, 1991).  
Inspiration is controlled via the brainstem within the ventral and dorsal respiratory groups, 
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which activate premotor neurons, and phrenic motorneurons located within the ventral horn of the 
cervical spinal cord segments 3-6 (Berger, 1979; Gordon, 1990; Loewy & Burton, 1978). External 
intercostal muscles then contract to elevate the anterior rib cage and that contraction draws down 
the diaphragm (Troyer, 1985). Simultaneously, the posterior cricoarytenoid (laryngeal abductor) 
activation allows for passage of air through the glottis (the space between the vocal folds) 
(Berkowitz, Chalmers, Sun, & Pilowsky, 1999). Laryngeal adductors (thyroarytenoid, lateral 
cricoarytenoid, and interarytenoids) slightly narrow the glottis during post inspiration (Poliacek, 
Stransky, Jakus, Barani, Tomori, & Halasova, 2003). Neurons whos cell bodies are within the 
spinal cord termed ‘motoneurons’ supply a method of activation to muscles; the motoneruons that 
move muscles within the larynx can be found in the caudal brainstem near the nucleus 
retroambiguus (Berkowitz, Chalmers, Sun, & Pilowsky, 1999; Bieger & Hopkins, 1987). 
Expiration during quiet breathing occurs as a result of passive recoil from the lungs and 
negative atmospheric pressure (relative to thoracic pressure) (Iscoe, 1998), allowing air to be 
expelled (Campbell, 1955). Minimal abdominal motor drive occurs during the expiratory phase of 
eupnea (Abdala, Rybak, Smith, & Paton, 2009). Attachment of the lungs to the chest wall via the 
pleural space allows for movement of the lungs during breathing (Agostoni, 1986). 
Essential gases such as oxygen, carbon dioxide, and hydrogen are monitored in the body 
by peripheral chemoreceptors within the carotid and aortic bodies; they then project to the NTS 
(Donoghue, 1985). These receptors drive neuron activity within the brainstem and sleep-wake 
centers, which then moderate interactions with other airway protective pattern generators (cough, 
swallow, etc.) (Guyenet, Mulkey, Stornetta, & Bayliss, 2005; Lindsey, Ott, Nuding, Segers, 
O'connor, & Morris, 2011). Their interactions are also termed “reconfiguration.” More 
specifically, to describe changes in excitability of eupnea neural network components; these 
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networks are altered based on evaluation of incoming sensory information into the nucleus tractus 
solitarius (NTS) (Baekey, Morris, Gestreau, Li, Lindsey, & Shannon, 2001; Lindsey, Hernandez, 
Morris, Shannon, & Gerstein, 1992; Pitts, Morris, Segers, Poliacek, Rose, Lindsey, Davenport, 
Howland, & Bolser, 2016; Pitts, Rose, Mortensen, Poliacek, Sapienza, Lindsey, Morris, 
Davenport, & Bolser, 2013a; Rose, Pitts, Poliacek, Davenport, Morris, & Bolser, 2011; Shannon, 
2000). 
In vivo translational research studies have elucidated the sensory-neural pathways that 
regulate breathing/eupnea. Cranial nerve X, the vagus, arises from the inferior and superior vagal 
ganglia (nodose and jugular respectively) and relays (transports) lung sensory information 
(Canning, Mazzone, Meeker, Mori, Reynolds, & Undem, 2004; Ootani, Umezaki, Shin, & Murata, 
1995). Lung sensory receptors differ in both chemical and mechanical responsiveness, anatomical, 
embryological, and physiological attributes. They send information to the brainstem respiratory 
network.  
Alterations of the Eupneic/Breathing Pattern 
It is theorized that the rhythm of breathing may be altered for many reasons such as 
sneezing, coughing, exercise, and breath holding. Complicated fine motor behaviors such as 
speaking and swallowing also may change the basic rhythm of breathing. Essential human 
functions such as swallowing and respiratory defensive actions such as coughing may be 
disordered and thus are a specific area of interest to researchers. The primary function of the lungs 
is to allow for ventilation or the exchange of oxygen and carbon dioxide. Oxygen is moved into 
the blood stream and carbon dioxide is removed. West (1995) describes a series of fundamental 
input, processing, and output interactions between pulmonary and cardiac systems to produce 
breathing and allow for ventilation. The input system is comprised of higher brain activity (cortex 
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and limbic system) that receives information from mechanoreceptors and chemoreceptors. 
Mechanoreceptors are afferent (sensory) receptors that respond to changes in the airway 
and lungs. Mechanoreceptor subtypes can be classified based on the rate of adaptation. Adaption 
refers to how the sensory system changes in terms of the responsiveness to a stimulus after a 
constant stimulus is presented (Canning, Mori, & Mazzone, 2006). These subtypes include: 1) 
slowly adapting pulmonary stretch receptors (SARs); 2) rapidly adapting pulmonary irritant 
receptors (RARs) (Canning, Farmer, & Mori, 2006; Canning, Mori, & Mazzone, 2006); 3) 
bronchopulmonary C-fibers (afferent) that can be intrapulmonary, extra pulmonary, tracheal, or 
bronchial (Canning, Farmer, & Mori, 2006); 4) intrapulmonary juxtucapillary or also termed “J-
receptors” which react to pulmonary edema or pneumonia (Canning, Farmer, & Mori, 2006; West, 
1995); and 5) baroreceptors that come in through the nucleus tractus solitarius (NTS) and excite 
cells in the aorta in response to the stretch of blood vessels (Ott, Nuding, Segers, Lindsey, & 
Morris, 2011). 
Chemoreceptors sense changes in blood gases including oxygen (O2), carbon dioxide 
(CO2), pH concentrations, and can be described anatomically in terms of peripheral (airway) and 
central (neural) loci (Heymans, 1927). They have been described as the most important regulators 
of breathing (Buchanan, 2013). Peripheral chemoreceptors (aortic and carotid) have many 
important roles to regulate gas exchange function and are responsible for 25% of chemoreceptor 
drive of ventilation (Lahiri, 1975). Peripheral chemoreceptors stimulate respiration under the 
following conditions: 1) during changes in arterial PO2 (decreased oxygen in arteries and tissue) 
(Green, 1986); 2) during changes in blood pH (non-respiratory problems such as metabolic 
alkalosis and acidosis); and 3) during depression of central chemoreceptors (Dejours, 1962; 
Dejours, 1963; Hornbein, 1961). Under the influence from anesthesia or narcotics; peripheral 
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chemoreceptors may become the primary stimulus for ventilation (Takakura, Moreira, Colombari, 
West, Stornetta, & Guyenet, 2006). Central chemoreceptors are responsible for 75% of central 
drive for ventilation and they are sensitive to hydrogen and CO2 changes in extracellular fluid. 
When there is a high level of CO2 in the blood, an inspiration is triggered to promote ventilation 
(Li & Nattie, 1997; Lindsey, Ott, Nuding, Segers, O'connor, & Morris, 2011).  
The ventilation processing system includes respiratory neurons located within the 
brainstem and spinal cord; they receive mechanical information from the lungs and chemical 
information from hemoglobin and blood buffers (West, 1995). The incoming pulmonary afferent 
information is vagally mediated and processed by second order interneurons in the (NTS) (Kubin, 
Alheid, Zuperku, & McCrimmon 1985, 2006). Motor drive is then provided to the chest  
 
Figure 1.1. Schematic that combines the function of the mechanoreceptors and 
chemoreceptors with basic input-processing-output systems.* 
*Input-processing-output schematic generated from material on respiration (Buchanan, 2013). 
 
wall (Shiba, 2007). The output system includes respiratory muscles, lung and chest wall, alveolar 
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capillary membrane and hemoglobin and blood buffers (West, 1995).  
Ventilation is a complex and carefully orchestrated process involving the coordination of 
peripheral and central processes; it sustains life. The respiratory musculature also supports and 
produces other airway protective behaviors including cough and swallow. For a successful cough 
and swallow to occur, both functioning peripheral and central processes must be coordinated 
with eupnea. It has been shown that cough and eupnea share similar premotor neuron firing 
patterns during eupnoea and cough (Baekey, Morris, Gestreau, Li, Lindsey, & Shannon, 2001). 
Successful coughing and swallowing also require the appropriate functional anatomy and 
musculature. Understanding the neural and physical alternations of breathing for cough and 
swallow allow for the proper evaluation and treatment of disordered cough and swallow. The 
following sections will review the mechanisms of cough and swallow as alterations from the 
basic breathing rhythm.  
 Cough 
Cough is vital behavior that assists in preserving the gas-exchange function of ventilation by 
clearing foreign material such as aspirate (any inhaled matter or secretions) (Dicpinigaitis, 2007; 
Widdicombe & Fontana, 2006); the motor act of a cough can be triggered at multiple locations 
within the upper areodigestive and respiratory tracts a such as, the larynx, trachea, or bronchi.3 The 
European Respiratory Society (ERS) states that cough is a “three-phase motor act” (Morice et al., 
2007, p. 1256). An effective cough requires high velocity airflow and that airflow usually results 
from three phases: 1) inspiration; 2) compression; and 3) expulsion (Castillo & Pitts, 2013; Fontana 
                                                 
3 (Bolser, 1991; Bolser & Davenport, 2000; Bolser, Degennaro, O'reilly, Chapman, Kreutner, 
Egan, & Hey, 1994; Forsberg & Karlsson, 1986; Gestreau, Milano, Bianchi, & Grelot, 1996; Jakus, 
Poliacek, Halasova, Murin, Knocikova, Tomori, & Bolser, 2008; Pitts, 2012; Poliacek, Wang, 
Corrie, Rose, & Bolser, 2010; Rose, Pitts, Poliacek, Davenport, Morris, & Bolser, 2011). 
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& Widdicombe, 2007; Pitts, Bolser, Rosenbek, Troche, Okun, & Sapienza, 2009; Pitts, Bolser, 
Rosenbek, Troche, & Sapienza, 2008; Pitts, Morris, Segers, Poliacek, Rose, Lindsey, Davenport, 
Howland, & Bolser, 2016; Pitts, Rose, Mortensen, Poliacek, Sapienza, Lindsey, Morris, 
Davenport, & Bolser, 2013a; Smith Hammond C.A. , 2001; Smith Hammond, Goldstein, Horner, 
Ying, Gray, Gonzalez-Rothi, & Bolser, 2009).  
During inspiration the diaphragm and chestwall muscles (parasternal and external intercostals) 
contract to rapidly increase lung volume (Hanacek, Davies, & Widdicombe, 1984; Langlands, 
1967; Lavietes, Smeltzer, Cook, Modak, & Smaldone, 1998; Loudon & Shaw, 1967; Mccool, 
2006). Next, the vocal folds come together (adduct) and expiratory muscles contract; this is 
referred to as the “compression phase” and at this time, subglottic pressure increases (Mccool, 
2006). Abduction of the vocal folds marks the beginning of the expiratory phase.  The expiratory 
muscles continue to contract generating high airflow rates that may reach up to 12 liters per second 
(L/s) in normal healthy adults (Langlands, 1967). Cough is a vital airway protective behavior and 
can be initiated via laryngeal and tracheal sensory afferents via a brainstem pattern generator 
(Morris, Arata, Shannon, & Lindsey, 1996; Mutolo, Cinelli, Bongianni, & Pantaleo, 2014; 
Poliacek, Corrie, Rose, Wang, & Bolser, 2008; Poliacek, Rose, Corrie, Wang, Jakus, Barani, 
Stransky, Polacek, Halasova, & Bolser, 2008). 
The production of cough may appear rudimentary to novel observers, however it is a very 
complex motor act involving the coordination of multiple physiological systems as well as 
neurological networks. Understanding of the neural bases of cough and motor output drive is 
necessary in order to effectively target pharmacological treatment and/or to manage impaired 
cough (Mutolo, Bongianni, Cinelli, Fontana, & Pantaleo, 2008; Poliacek, Plevkova, Pitts, 
Kotmanova, Jakus, & Simera, 2016; Shannon, Baekey, Morris, Nuding, Segers, & Lindsey, 2004). 
 12 
 
Cough is a vagally mediated behavior, which can be activated by myelinated and non-myelinated 
vagal afferent nerves; it is diminished by anesthesia and eliminated by vagotomy (Canning, 
Mazzone, Meeker, Mori, Reynolds, & Undem, 2004; Canning, Mori, & Mazzone, 2006). 
Peripheral afferent fibers detect stimuli in the laryngeal and pulmonary mucosa. Data based 
on in vivo cat, rabbit and guinea pig models indicate that non-myelinated C-fibers (specifically in 
the carina) respond to chemical irritants (Sant'ambrogio, Sant'ambrogio, & Davies, 1984). 
Messages are sent ascending through the dorsal root ganglion to second-order neurons in the 
nucleus tractus solitarius (NTS) (Kubin, Alheid, Zuperku, & Mccrimmon, 2006; Kubin, 1985). 
Central pattern generators (CPGs), or groups of neurons in the brainstem and medulla, respond to 
incoming sensory information and regulate descending neural drives. Pontine and medullary 
respiratory neurons send descending motor drives to muscles of inspiration and expiration for 
production of the cough. The neurophysiology of cough requires precise temporal activation and 
suppression of neural networks (Bolser, Poliacek, Jakus, Fuller, & Davenport, 2006). 
Two distinct types of defensive reflexes of the respiratory tract are described throughout 
the literature: 1) cough (Leith, 1977), and the 2) expiration reflex (Williams, 1841). Although both 
reflexes can be induced by mechanical and chemical irritation to the aerodigestive and respiratory 
tracts, they differ in the sensory pathway that are activated within the brain and also the central 
nervous system circuits which control the behaviors (Widdicome & Fontana, 2006). Cough and 
expiration reflex also differ in terms of the presence of a pre-explosive inspiratory phase. 
Expiratory reflex does not have the inspiratory effort prior to the expulsion of air. 
Swallow  
Swallowing encompasses the integration of a complex sensory and motor system that is 
under both reflexive and voluntary control. Normal swallowing is a continuous series of events 
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that scientists and clinicians conceptually divide into “phases”; these three phases are: oral 
prepatory, oral, pharyngeal, and esophageal (Doty, 1968; Logemann, 1984; Miller, 1982). Some 
literature report a pre-oral prepatory phase prior to mastication, where neural activity begins and 
the body anticipates bolus (material swallowed) delivery (Leopold, 1997). Single and consecutive 
swallow events require precise temporal integration of neural activity and muscle movements; with 
this, muscle movements within the throat are coordinated and permit food and liquid to flow 
through the pharynx and into the esophagus (food pipe). The process of swallow and the associated 
motor movement of the oral structures and larynx have been well defined in the literature (Doty, 
1956) as a series of chambers and valves that participate to allow for safe passage of a bolus 
through the oral cavity and pharynx and then safely into the esophagus (Dodds W.J, 1990; Kahrilas 
& Logemann, 1993; Logemann, 1998; Olthoff, Zhang, Schweizer, & Frahm, 2014).  
During the pharyngeal stage of swallow, the soft palate elevates to meet the pharyngeal 
wall; this velopharyngeal valve closes off the passageway to the nasal cavity and allows for buildup 
of pressure within the pharynx (Kahrilas, 1993; Logemann, 2007). Following elevation of the 
pharynx, the larynx elevates through contraction of submental muscles which move the hyoid bone 
superiorly and anteriorly; subsequently, three levels of laryngeal airway protection ensue 
(Logemann, 1984). Multiple valves begin to close off the passage to the airway as food or liquid 
passes through the pharynx (Logemann, 2007). The pharyngeal phase of swallow is described as 
the following behavioral sequence:  1) the epiglottis inverts; 2) the ventricular folds and arytenoid 
cartilages move to a medial position; 3) the vocal folds adduct, sealing the passage to the to the 
airway within the larynx (Logemann, 2007); and 4) the superior portion of the esophageal sphincter 
(UES) relaxes (Kahrilas P.J., 1988; Logemann, 1984, 2007). These actions result in the bolus 
passing through the UES into the esophagus completing the pharyngeal phase.  
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A single swallow takes less takes less than 2 seconds to complete and within that time, 
twenty-six pairs of muscles and five cranial nerves coordinate sensory and motor actions. The 
neurologic network underpinnings of swallow are not completely understood; however, brainstem 
control of the swallowing process has been investigated in vivo (Gestreau, 1996; Mogoseanu, 
1993, Jean, 2001). The neural network for swallowing is sophisticated and involves carefully 
organized connections between respiratory and cough neural networks (Gestreau, 1996; Pitts, 
2012).  
Mechanisms of a swallow central pattern generator (CPG) are discussed in the literature as 
an organization of central control of swallowing (Ertekin & Aydogdu, 2003). The swallow CPG 
is located in the brainstem and is comprised of two distinct areas, dorsal and ventral. The dorsal 
population is within nucleus tractus solitaries (NTS) and while the ventral swallow group is a 
group of pre-motor neurons within the nucleus ambiguous (NA) (Ertekin & Aydogdu, 2003). This 
extensive network provides control and regulation of over the swallow process (Ertekin & 
Aydogdu, 2003) both augmenting and decrementing-descending motor drives to muscles. Pre-
motor neurons relay information to motor neurons, which in turn send drives to muscles. “Behavior 
control assemblies” or BCAs represent additional networks within the system that are theorized to 
regulate processes of respiration, cough, and swallow by overriding CPGs (Bolser, Poliacek, Jakus, 
Fuller, & Davenport, 2006). It is suggested that, if there is a disruption to the peripheral-sensory, 
central-neural motor, anatomical-structural mechanisms, or a combination of each, then the 
swallow behavior will be disordered. 
Cough and Swallow: Shared Neural and Anatomical Space 
Cough and swallow are remarkably coordinated behaviors both in terms of neuronal 
activity and shared anatomical structures. As aforementioned, afferent (sensory) information is 
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being processed in the NTS which activates the central generators. The CPG then drives the pre-
motor and motor neurons-activate muscles stimulating the superior laryngeal nerve to produce 
both cough and swallowing. Evidence shows that there are both shared neural and anatomical sub 
straights; a shared NTS (Gestreau, 1996); shared pre-motor neurons (Shiba K., 2007) and muscle 
activity (Pitts, Rose, Mortensen, Poliacek, Sapienza, Lindsey, Morris, Davenport, & Bolser, 
2013b). Below is a review of these interconnectivities.  
Neuronal Activity 
Neural networks and activation patterns for breathing, cough, and swallow have both 
shared and distinct properties (Dick, Oku, Romaniuk, & Cherniack, 1993; Gestreau, 1996). As 
previously discussed, CPGs in the brainstem regulate the process of eupnea. CPGs must be flexible 
in their connectivity to allow for rapid change between behaviors of breathing, swallowing, and 
coughing. Coordination and/or presence of both cough and swallow has been proposed as being a 
“meta-behavior” (Pitts, Rose, Mortensen, Poliacek, Sapienza, Lindsey, Morris, Davenport, & 
Bolser, 2013b) in that a central control system coordinates the motor output of the distinct CPGs 
for either a cough behavior or swallow. Jean (2001) proposed that the shared CPG for swallow and 
breathing is located within the brainstem in the area of the nucleus ambigus (NA), dorsal 
respiratory group (DRG), and ventral respiratory group (VRG). Evidence of a flexible neural 
system was discovered as Gestreau and colleagues (1996) examined the intracellular response of 
33 neurons in the DRG during fictive swallowing. In the experiment by Dr. Gestreau and 
colleagues, superior laryngeal nerve (SLN) afferent fibers were stimulated to produce a fictive 
swallow. DRG neurons exhibited swallow-related burst activity in response to SLN stimulation 
(Gestreau et al., 1996). Results indicated that neurons in this region might be “flexible” in their 
functions and adapt to incoming stimuli. Rapid timing between changes from swallow to cough 
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behavior offer further evidence of shared and flexible underpinnings (Bolser, 2002). Authors 
describe the multi-synaptic connections within respiratory neural networks that allow for the 
prompt behavior selection; coughing immediately in response to tracheal irritants such as 
aspiration. 
Neurons that are firing during respiration have also been shown to fire during swallow. 
Bulbospinal inspiratory modulated neurons in the nucleus tractus solitaries (NTS) are depolarized 
(making the cell positively charged) and exhibit burst activity during swallowing (Bautista, 2014; 
Jean, 2001). Propriobulbar inspiratory modulated neurons also are activated during swallow 
(Gestreau et al., 1996). This inspiratory neuronal activity may be responsible for the 
“shluckatmung” (Spearman, 2014). The “shluckatmung” is a term for the “swallow breath,” which 
is a burst of phrenic activity during swallow (Spearman, 2014). Evidence of the shluckatmung was 
shown by EMG recordings of increased parasternal activity and neuroanatomical connectivity 
related to the behaviors of cough and swallow in the feline model (Pitts, Rose, Mortensen, 
Poliacek, Sapienza, Lindsey, Morris, Davenport, & Bolser, 2013b). This has also been shown in 
humans and goats (Feroah, Forster, Fuentes, Lang, Beste, Martino, Pan, & Rice, 2002; Hardemark 
Cedborg, Sundman, Boden, Hedstrom, Kuylenstierna, Ekberg, & Eriksson, 2009). 
Higher order cortical processing may also be a part of the shared coordination of the neural 
systems. Computational modeling incorporating shared cortical networking components has 
derived motor activity outputs resembling in vivo studies (Olthoff, Zhang, Schweizer, & Frahm, 
2014). The models elucidate additional shared networks participating in the coordination of 
swallow and cough behaviors.  
Anatomical Structures  
Breathing, swallowing, and cough share common anatomy. As the central pattern generator 
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within the brain evaluates information regarding the quality of the swallow (i.e., if the swallow is 
safe or unsafe), motor activation within respiratory muscles change (Pitts et al., 2013). Peripheral 
afferent fibers lining the mucosa of the larynx and trachea detect aspiration by informing the 
swallow CPG (Pitts, Morris, Lindsey, Davenport, Poliacek, & Bolser, 2012). The pharyngeal 
muscles have been described as having a dual role including as a passive participant in the 
movement of food through the pharynx as well as functioning as a sensory feedback system for 
cough production (Pitts et al., 2013). Pitts (2013) described suppression of the thyropharyngeus 
muscle activity during cough in an animal model and proposed that this activity is meant to protect 
the airway by collecting food and liquid that has not been completely expelled.  
The “dual valve hypothesis” proposed by Pitts and collogues (2013) is based on a 
mechanism within the brainstem control network that prepares the pharynx (swallow modulated 
muscles) for cough behavior. These researchers suggest that the upper esophageal sphincter (UES) 
and larynx act together to coordinate thyropharyngeus suppression. During a swallow the glottis 
is closed and the UES is open allowing passage of bolus material (Logemann, 1985, 2007; Pitts, 
2013); this seals the trachea for airway protection and maintains pressures for passage of bolus 
material. During the compression phase of cough, both the larynx and UES are maximally closed 
and this closure maintains intrathoracic pressure to promote the effectiveness of a cough (Pitts, et 
al., 2013).  
Examination of temporal musculature relationships between cough and swallow behaviors 
has been studied in vivo (Pitts et al, 2013). Bipolar fine-wire electrodes were used to obtain 
electromyograms (EMGs) in conjunction with esophageal pressures; wires were placed in seven 
muscles to assess the presence of cough and swallow behaviors (Pitts et al., 2013). Mechanical 
stimulation to the trachea induced cough and injection of water into the pharynx induced swallow; 
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tracheal aspiration was induced with a water bolus presentation (Pitts et al., 2013). Results of this 
study showed that, after introduction of water to the oropharynx, cough EMG recordings had 
significantly greater amplitudes from parasternal, rectus abdominis, and thyropharyngeus muscles 
as well as positive esophageal pressure (Pitts et al., 2013). Abdominal muscle activation during a 
swallow activity provided evidence of shared physiological processes. This study was the first to 
show alteration of the posterior pharyngeal constrictor during cough, exhibiting the physiological 
coordination of mechanisms between cough and swallow.  
 “Behavior selection” is the concept that airway protective decision making, which occurs 
via afferent feedback, occurs on a moment-by-moment basis (Bolser, Pitts, & Morris, 2011). It is 
suggested that actions that require little central processing take “precedence” over centrally-
mediated processes and can block centrally-mediated behaviors until the brainstem-controlled 
behaviors are completed. Thus, the brainstem-controlled swallow action may take precedence over 
centrally-mediated breathing. The apneic period (moment of not inhaling/exhaling during a 
swallow) is evidence of pattern selection.  
Foundational knowledge of the neural and physiological underpinnings of breathing, 
swallowing, and coughing is essential to understand dystussia in patient populations. Even in the 
absence of brainstem impairment, neurogenic populations that have both upper and lower motor 
neuron dysfunction may exhibit concurrently impaired cough and swallowing (Hegland, Okun, & 
Troche, 2014; Pitts, Bolser, Rosenbek, Troche, & Sapienza, 2008; Plowman, Watts, Robison, 
Tabor, Dion, Gaziano, Vu, & Gooch, 2016; Smith Hammond, 2001).  
Gating of Airway Protective Behaviors 
Central processing of afferent stimuli can significantly modify cough and swallow 
excitability.  This action is termed “gaiting”  (Bolser, Poliacek, Jakus, Fuller, & Davenport, 2006), 
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and can result in hyper- and hypo-excitability of the cough (Morice, Jakes, Faruqi, Birring, 
Mcgarvey, Canning, Smith, Parker, Chung, Lai, Pavord, Van Den Berg, Song, Millqvist, Farrell, 
Mazzone, & Dicpinigaitis, 2014). Although gaiting is often considered to be under automatic 
control, we are beginning to understand that the cortex can significantly modulate cough 
excitability (Vertigan, 2008). Davenport and colleagues (2008) demonstrated that in response to a 
reflexive cough challenge all subjects first experience a sensation.  The authors then went on to 
measure this sensation termed the “Urge to Cough”. They ultimately proposed that supramedullary 
(cortical) input to the brainstem cough CPG is intimately involved in the ultimate magnitude of 
the cough motor response.  
The conclusions of many animal-model studies are consistent with the premise that motor 
control of cough is under automatic control from brainstem CPGs. However, the “Urge-to-Cough” 
model (Davenport, 2008) presents a representation of a feedback loop, which supports the presence 
of a cortical component of the cough system.  
“There are six stages to the cough ‘motivation-to-action’ model: 1) stimulus - trigger for 
neural event; 2) urge - the physical need to respond; 3) desire - translation of urge to a 
central neural targeted goal; 4) action - physical response that satisfies the urge-desire; 5) 
evidence - feedback to the neural system on the action; and 6) reward - sensory system that 
determines if the urge was satisfied (Davenport, 2008, p. 107)”. 
Taking into account the motivation-to-action model, researchers have studied higher-level cortical 
involvement, or the conscious decision making during the production of a cough. Hegland et al. 
(2012) administered capsaicin to 20 healthy adults; they were asked to modify their cough response 
including shorter/softer and longer/louder coughs. Results showed that individuals could 
voluntarily modify the reflexive behavior even under exposure to irritants (Hegland et al., 2012). 
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Additional evidence to support a cortical component to cough regulation includes a blunted 
affernet C-fiber response to stimulation in an anesthetized, in vivo preparation (Moreno-Lopez, 
Perez-Sanchez, Martinez-Lorenzana, Condes-Lara, Rojas-Piloni, 2013). The ability to voluntarily 
gate a response to sensory stimuli implies cortical processing of the cough response in humans.   
Descending motor drive signals are activated in a graded manner (Davenport, 2008). 
Depending on the strength of the stimulus, either a high concentration of an irritant or verbal 
instruction to produce a “strong cough,” the resulting cough behavior will be related to the stimulus 
(Davenport, 2008). Therefore, it is essential to note that the specific directions given to human 
subjects when eliciting a voluntarily induced cough may be related to the strength of voluntary 
cough production.  
Dystussia and Cough Measurement  
The presence of dystussia has multiple negative health implications in a variety of patient 
populations (Nakajoh K., 2000). Understanding cough as it is related to airway safety in a variety 
of clinical populations will have major health care implications as we can possibly detect early 
signs of swallowing impairment or rehabilitate cough for improved airway protection. It is an 
advancing area of research in both the basic science and clinical science research realms. Cough 
production is a measurable physiologic phenomenon. Objective measures of cough can be obtained 
using different elicitation methods such as inducing a reflexive cough or prompting a voluntarily 
induced cough. Cough evaluation tools include cough monitors, perceptual assessment, evaluating 
acoustic characteristics, and physiologic measurement. Each evaluation tool and cough elicitation 
method provides unique and valuable objective information about cough function. 
Reflexively and Voluntarily Induced Cough 
Elicited or induced cough is frequently tested with flow dosimeters or nebulizers to 
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administer irritant gases; these irritants may include but are not limited to capsaicin, citric acid 
aerosols, and fog (Fontana & Widdicombe, 2007). This methodology directly evaluates 
responsiveness of the afferent system. Induced cough is often associated with an expiratory reflex 
as there may be an absent or reduced inspiratory effort. Binary outcomes (present/absent) of cough 
production are typically recorded as well as quantifying the number of coughs produced, and time 
to cough production. Recording airflow waveforms produced during a cough effort may also be 
coupled with the administration of irritants.  
Voluntary cough is acquired by having the patient cough upon command to a verbal 
stimulus. It consists of a multistage event including an inspiration, closure of the vocal folds during 
a compression phase, and a forced expiration. Possible outcome measures include objective 
airflow measures, subjective ratings, and acoustic properties.  
Airflow Measurement 
Both induced and voluntary cough assessment methods allow for the acquisition of cough 
airflow data. Airflow data allows the clinician/researcher to gather information regarding the 
function of the respiratory system. Airflow values are dependent upon a number of variables 
including stimulus, laryngeal closure (build-up of subglottic pressure), expiratory muscle activity 
(Widdicombe, 2006) and in some cases inspiratory effort. Airflow waveforms are recorded by 
using an oral pneumotachograph, a device that measures rate of airflow, connected to a spirometer 
(pressure transducer) that then sends signals to a recording system to display waveforms on the 
computer (Pitts, Bolser, Rosenbek, Troche, & Sapienza, 2008; Smith Hammond, 2001). Cough 
production is recorded as a measure of airflow in liters (L) over time in seconds (L/s). Typical 
measures derived from the waveforms include temporal aspects of the cough, amplitude in L/s, 
and volume of expired airflow.  
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As illustrated in Figure 1.2, common objective measures of cough production that have 
been reported in previous research studies include, but are not limited to, inspiratory phase duration 
(IPD), inspiratory peak flow (IPPF), compression phase duration (CPD), expiratory peak flow 
(EPPF), expiratory rise time (EPRT), and cough volume acceleration (CVA); these terms are well 
described throughout the cough literature. CVA is described in the literature as a measure that is 
thought to be indicative of cough effectiveness (Bolser, 2002; Fontana & Lavorini, 2006; Smith 
Hammond C.A., 2001). To obtain outcome measures, waveforms are analyzed by identifying 
physical landmarks on the cough waveform. Data points are recorded and a series of calculations 
are made to obtain the final value for each objective measure. 
 
Figure 1.2 Same as Figure 2.1 which has been previously published in Watts et al, 2016, p. 
268, “Example of voluntary cough waveform measured with cough spirometry. Select derived 
objective measures are delineated on the waveform including: A) inspiratory phase duration; 
B) inspiratory peak flow; C) compression phase duration; D) peak expiratory flow rate; and E) 
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cough expired volume. Expiratory rise time is calculated by subtracting time at end of 
compression from peak expiratory flow time. Cough volume acceleration is not depicted but is 
calculated by dividing peak expiratory flow rate by the expiratory rise time.” 
 
Although testing methodology differs between elicited and voluntary cough, researchers 
suggest that airflow patterns of voluntary cough are similar to reflexive cough (Widdicombe & 
Fontana, 2006). When a cough is elicited by either an irritant or verbal command, there is a 
cognitive awareness of a need to cough; this is termed, “Urge-to-Cough” (Davenport, 2009). 
Authors suggest that this implies that cough has been activated via cortical neural pathways; 
specifically, the super pontine pathways have activated and the cognitive aspect of awareness and 
the urge precedes the behavior response in both elicited and voluntary cough (Hegland, Bolser, & 
Davenport, 2012).  
Sound Characteristics 
As cough is an audible physiologic event, acoustic and auditory perceptual characteristics of 
cough have also been investigated. Current methods that have been employed in current practice 
include a sound level meter to measure the sound pressure level (dB SPL) associated with a cough. 
In addition, cough has been characterized by having a rater listen to a cough and make subjective 
ratings (Laciuga, Brandimore, Troche, & Hegland, 2016). Subjective ratings of auditory perceptual 
characteristics of cough include but are not limited to: bovine, inadequate, weak, strong, wet, dry, 
productive, barking, hacking, present or absent. There is little consensus as to what these sound 
characteristic imply about the physiologic mechanism producing the cough.  Furthermore, 
perceptual ratings are limited by the arbitrary and or ordinal nature of the ratings and can be 
strongly biased by context while lacking desirably high inter- and intra-rater reliability (Shrivastav, 
2005).  
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Cough monitors vary in design and employ the use of a microphone in an attempt to 
objectively measure how many times the subject coughs in a given period of time. The recordings 
acquire an acoustic cough waveform. The European Respiratory Society (ERS) guidelines state 
that, for the assessment of acoustic recordings, cough is defined as “a forced expulsive maneuver 
or maneuvers against a closed glottis that are associated with a characteristic sound or sounds” 
Acoustic recordings of cough are quantified in a number of ways: 1) explosive cough sound 
(counting the explosive sounds waves); 2) cough seconds (time spent coughing); 3) cough breaths 
(how many coughs occur within breath group); and 4) cough epochs (cough sound that continues 
without a 2-s pause) (Morice et al., 2007).cough epochs (cough sound that continues without a 2-
s pause) (Morice et al., 2007). 
Dysphagia 
Dysphagia refers to difficulty swallowing and results as a symptom of a medical diagnosis 
rather than an etiology. Medical diagnoses that may lead to dysphagia include: neurologic 
diagnosis, connective tissue or rheumatoid disorders, structural diagnosis (e.g., tumors), Iatrogenic 
diagnoses, respiratory compromised conditions, esophageal disorders, and psychogenic conditions 
(Groher & Puntil-Sheltman, 2010). There is a reportedly wide range of patients (52-82%) with 
neurodegenerative diseases that are affected by oropharyngeal dysphagia (Clavé, 2004).  
Symptomology of dysphagia may include a combination of prandial (i.e., during 
swallowing) and post prandial coughing or choking, nasal or oral regurgitation of food or liquid, 
odynophagia (painful swallowing), labial spillage, unexplained weight loss, nutritional 
deficiencies (Groher & Puntil-Sheltman, 2010), halitosis, or sensation of food/pills getting “stuck” 
within the throat.  
Dysphagia impacts health, quality-of-life, and increases a patient’s financial burden (Da Costa 
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Franceschini & Mourao, 2015; Leow, Huckabee, Anderson, & Beckert, 2010; Maclean, Cotton, & 
Perry, 2009; Plowman-Prine, Sapienza, Okun, Pollock, Jacobson, Wu, & Rosenbek, 2009; Tabor, 
Gaziano, Watts, Robison, & Plowman, 2016) Subsequent aspiration pneumonia (lung infection) 
from severe untreated or unmanaged dysphagia constitutes a serious health concern (Delegge, 
2002). Aspiration in already medically compromised patients may lead to decreased hospital 
outcome and may cause death (DeLegge, 2002). In fact, dysphagia is associated with pulmonary 
sequelae and a leading cause of death in Parkinson’s disease (PD) (Hoehn & Yahr, 1967) and 
attributes to mortality in Amyotrophic Lateral Sclerosis (ALS) (Czaplinski A., 2006).  
Clinical Evaluation of Dysphagia 
Dysphagia assessment involves a variety of health professionals (Groher M.E., 2010). 
There are both clinical and instrumental (using high-tech instrumentation) approaches to dysphagia 
assessment. The “gold standard” instrumental assessment involves performing the Modified 
Barium Swallow Study (MBS) (Logemann, 1984). The MBS is a fluoroscopic imaging study in 
which the patient is given barium, an inert radiographic substance, to swallow and bolus flow 
through the oral cavity and pharynx are visualized. Other instrumental evaluation includes the 
Fiberoptic Endoscopic Evaluation of Swallowing (FEES). This methodology requires the clinician 
to pass a scope trans-nasally to view the laryngeal vestibule during swallowing tasks.  
Instrumental swallow evaluation affords direct visualization of the swallow process and 
thus, in the hands of a skilled clinician, can lead to an accurate diagnosis of oropharyngeal 
impairment. Assessment that does not require the use of instrumentation or radiography includes 
various non-instrumental clinical evaluations. The terms clinical swallow examination (CSE), or 
bedside swallow examination (C/B E) is used to describe this type of assessment (McCullough, 
2001, Logemann, 1984).  
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The CSE can be performed at the patient’s bedside but is not restricted to the bedside 
(Groher M.E., 2010) and does not include internal visualization of the swallow mechanism. CSE 
are widely used by SLPs to assess patients who are suspect of having oral or oropharyngeal 
dysphagia. During a CSE, clinicians carefully examine the structure and function of the oral 
mechanism and evaluate the oral phase of swallowing. Patients are commonly asked to complete 
a series of both swallowing and non-swallowing tasks; based on the patient’s performance, 
clinicians make determinations regarding swallow safety and the pharyngeal phase of the swallow.  
There are three main components to the CSE: 1) the medical history 2) physical inspection 
of swallow anatomy and musculature 3) swallow trials (Logmann 1984, Groher M.E., 2010). The 
purpose of the CSE is to accurately detect the presence or absence of a disordered pharyngeal stage 
of swallow without direct internal visualization of the anatomy. Instead, “clinical signs” are used 
to detect the presence of penetration or aspiration. The clinical assessment of swallow may consist 
of variations of these three main components. Several studies outline the predictive values of these 
measures in specific patient populations.  
Dysphagia, Dystussia, and Airway Protection  
Cough is a vital airway protection mechanism during swallowing; it acts as a sweeping 
mechanism to clear the lower airways of aspirant material (Bolser, 2002; Pitts, 2012; Smith 
Hammond C.A., 2001). Dystussia decreases an individual’s ability to protect their airway and thus, 
in certain neurogenic populations, can increase the risk for aspiration, dysphagia, subsequent 
aspiration pneumonia, and morbidity (Smith-Hammond 2009; Pitts, 2010). Normally, the cough 
reflex is an audible clinical indicator of aspiration. Therefore, the absence of a cough reflex in the 
event of aspiration may be an indicator of impairment (Pitts, 2013) as this may indicate poor 
sensory feedback response. Clinically, dystussia has been described in neurodegenerative disease 
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populations such as Parkinson’s disease (PD) (Pitts, Bolser, Rosenbek, Troche, & Sapienza, 2008, 
2010), stroke (Smith-Hammond et al., 2001; Smith-Hammond et al., 2009), and Amyotrophic 
Lateral Sclerosis (ALS) (Plowman, Watts, Robison, Tabor, Dion, Gaziano, Vu, & Gooch, 2016). 
Both respiratory and swallowing impairments are highly prevalent in individuals with Parkinson’s 
disease (PD) and Amyotrophic Lateral Sclerosis (ALS).  
Although it appears that voluntary cough production is related to airway protection status 
during swallowing in neurodegenerative disease populations, the methodology to test cough 
objectively is costly and the analysis labor intensive, time consuming, and requires intensive 
training to perform expert evaluation of physiologic cough waveforms. The current voluntary 
cough testing methodology is not a feasible method to utilize in busy clinic environments.  
Methods available to assess cough during a clinical swallowing evaluation without the use of 
airflow recordings include evaluating the strength of a cough (Daniels, 1998; Laciuga, 
Brandimore, Troche, & Hegland, 2016; Mccullough, 2001). This relies on the perception of 
“strength” and there is a lack evidence to support the reliability and validity of perceptual 
evaluation of voluntary cough (i.e., strength) for the purpose of clinically assessing swallowing 
function and airway protection mechanisms. While current clinical evaluation of cough is focused 
on cough frequency (how many times a person coughs), cough reflex testing (often using tussive 
agents), voluntary cough measures, and patient subjective ratings of severity, little is known 
regarding the reliability or validity of clinician perceptions of voluntary cough effectiveness or 
auditory characteristics of cough. Therefore, clinicians may not have the necessary tools to 
describe impaired cough, and its role in dysphagia screening may be currently underutilized.   
Critical research questions to address include: 1) what clinical swallowing assessments are 
available to assess cough; 2) what voluntary cough assessment methods are speech language 
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pathologists using in their clinical practices; 3) what physiologic features of cough are useful in 
determining the presence of a swallowing disorder; 4) what, if any, novel, objective, acoustic 
parameters of voluntary cough are useful in detecting the presence of a swallowing disorder?  
The relevance of such work is paramount for professionals who serve populations with 
impaired swallow ability as traditional methods of clinical swallowing assessment often fail to 
identify those with impaired swallowing who silently aspirate (i.e., no reflexive cough). Current 
binary subjective measures (i.e., strong/weak) used during clinical swallow assessments fail to 
provide quantitative data or describe deviant auditory features of cough. There remains a need to 
investigate novel methodologies to assess voluntary cough in humans for the purposes of 
evaluating swallowing dysfunction. The results of such studies may lead to more sensitive and 
specific means of speech-language pathologist’s clinically assessing swallow function and may 
provide better health outcomes for patients. Although there are studies that focus on the 
relationship between cough and swallow, there is a paucity of data on clinician reliability of 
assessing cough function, or deviant audible features of dystussia which may inform clinicians of 
decreased airway protection.  
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CHAPTER TWO:  
 
TO COUGH OR NOT TO COUGH? EXAMINING THE POTENTIAL UTILITY OF 
COUGH TESTING IN THE CLINICAL EVALUATION OF SWALLOWING 
 
Note to Reader 
 This article has been previously published in Current Physical Medicine Rehabilitation 
Reports, 2016, 4: 262-276, and has been reproduced with the permission of Springer Publishing 
(Appendix A).  
Introduction 
Dysphagia (impaired swallowing) impacts the ability of an individual to consume oral 
intake safely and efficiently. Dysphagia accounts for approximately 7% of hospital admissions in 
the United States (Altman, 2011; Altman, 2010) and is estimated to have a total economic burden 
of approximately $547 million dollars per year (Cichero, 2012). Impairments in swallowing 
efficiency refer to difficulties transporting foods and liquids from the oral cavity into the stomach 
that result in residue in the oral cavity, pharynx, and esophagus, and that are linked to malnutrition 
(Moreira, 2016). Impairments in airway safety occur when ingested foods or liquids enter the 
airway (i.e., penetration or aspiration) and are linked to increased pneumonia risk (Cabre, Serra-
Prat, Force, Almirall, Palomera, & Clave, 2014). The inability to eat or drink by mouth is 
associated with reductions in mental well-being, quality of life, and increased caregiver burden 
(Cichero, 2012; Leow, Huckabee, Anderson, & Beckert, 2010; Maclean, Cotton, & Perry, 2009; 
Paris, Martinaud, Hannequin, Petit, Cuvelier, Guedon, Ropenneck, & Verin, 2012; Plowman-
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Prine, Sapienza, Okun, Pollock, Jacobson, Wu, & Rosenbek, 2009; Tabor, Gaziano, Watts, 
Robison, & Plowman, 2016). These life-threatening and psychosocial sequelae of dysphagia 
necessitate timely and accurate identification of swallowing impairment in at-risk individuals to 
optimize safe oral intake, pulmonary health, and quality of life.  
Evaluation of swallowing begins with a “bedside” or clinical swallow examination (CSE). 
The CSE typically includes a review of patient history, patient-reported symptoms, assessment of 
the oral mechanism, and observation of liquid and food swallowing trials (Suiter, 2012). 
Subsequent instrumental evaluation may be performed at the clinician’s discretion, if clinical signs 
or symptoms warrant further evaluation, and pending the availability of resources. The 
Videofluoroscopic Swallow Study (VFSS) represents the gold standard instrumental swallowing 
assessment. It constitutes the only type of assessment with direct visualization of both the oral and 
pharyngeal phases of swallowing to confirm specific impairments in swallowing that maybe 
suspected during the CSE, and affords the ability to determine specific contributing mechanisms 
of oral, pharyngeal and often esophageal stage impairments (Logemann, 1984). Although VFSS 
represents the gold standard instrument, many clinicians may rely solely on the CSE given limited 
or no access to VFSS (Association, 2000). Another instrumental evaluation technique, the 
fiberoptic endoscopic evaluation of swallowing (FEES), is a useful tool in providing a 3-
dimensional visualization of the pharyngeal stage of swallowing. FEES is noted to provide 
superior and direct imaging of pharyngeal anatomy, secretions, and vocal fold movement, however 
is limited in its application in many settings due to access to equipment and skill level of the 
clinician. 
Since the CSE does not permit direct visualization of the swallowing process, its ability to 
accurately identify individuals who ‘silently’ aspirate (i.e., no cough in response to material 
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entering airway) has been identified as a major limitation (Miles, Moore, Mcfarlane, Lee, Allen, 
& Huckabee, 2013; Plowman, Watts, Robison, Tabor, Dion, Gaziano, Vu, & Gooch, 2016; Smith 
Hammond, 2008). For example, one study documented that the CSE identified only 30% of 
radiographically confirmed aspirators in 107 hospitalized patients (Splaingard Ml, 1988). 
Considering this limitation, research has focused on determining the sensitivity and specificity of 
various validated clinical tools, screeners and clinical signs to identify dysphagia or aspiration in 
order to improve the utility of the CSE (Mccullough & Martino, 2013; Mccullough, 2005, 2001; 
Rosenbek, Mccullough, & Wertz, 2004). For example, can tasks identifying poor lingual 
movement discriminate safe versus unsafe swallowing? Determining components of the CSE that 
accurately detect swallowing safety and efficiency during swallowing is a significant research 
initiative and may reduce error during CESs.  
Although the American Speech Language Hearing Association (ASHA) provides 
guidelines for performing an instrumental evaluation of swallowing (Karen Dikeman, 2003), only 
practice recommendations (and no published guidelines) exist for the CSE (Association, 2000). 
As a result, current CSE protocols vary widely, and might constitute use of a validated CSE tool 
(see Table 2.1) or combinations of various standardized assessments. Further, procedural policies 
for conducting a standardized CSE are limited and, given the variability in clinical practice 
patterns, dysphagia recommendations and management strategies also vary (Mathers-Schmidt & 
Kurlinski, 2003). suggests that cough airflow measures may serve as a useful physiologic metric 
to index airway defense capabilities in at-risk individuals (Anna Miles 2013; Hegland, Okun, & 
Troche, 2014; Pitts, Bolser, Rosenbek, Troche, & Sapienza, 2008; Pitts, Troche, Mann, Rosenbek, 
Okun, & Sapienza, 2010; Plowman, Watts, Robison, Tabor, Dion, Gaziano, Vu, & Gooch, 2016; 
Sato, Tohara, Iida, Wada, Inoue, & Ueda, 2012; Smith Hammond C.A. , 2001; Smith Hammond, 
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Goldstein, Horner, Ying, Gray, Gonzalez-Rothi, & Bolser, 2009). Cough function has been an area 
of increasing interest in the evaluation, management, and treatment of dysphagia (Plowman, Watts, 
Robison, Tabor, Dion, Gaziano, Vu, & Gooch, 2016). This is not surprising given the crucial role 
cough serves in defending the airway during swallowing. Indeed, recent research highlights a close 
relationship between voluntary and reflexive cough airflow measures and airway safety status 
during swallowing; emerging data The purpose of this narrative review is to examine the 
relationship between cough and swallow, summarize current validated CSE’s, and review the 
discriminant capacity of both voluntary, and reflexive, cough testing to detect unsafe swallowing. 
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Relationship between Cough and Swallow 
Cough is a sensorimotor behavior involved in airway protection to forcefully eject foreign 
material from the laryngeal vestibule and lower airways (Bolser, 2002; Pitts, 2012; Ross, 1955; 
Smith Hammond C.A., 2001). An effective cough is therefore critical in removing aspirate material 
from the airway during swallowing, particularly in patients with additional co-morbidities who are 
more susceptible to developing pulmonary sequelae. In many neurogenic populations, dystussia 
(impaired cough) and dysphagia present in parallel (Hegland, Okun, & Troche, 2014; Pitts, Bolser, 
Rosenbek, Troche, & Sapienza, 2008; Pitts, Troche, Mann, Rosenbek, Okun, & Sapienza, 2010; 
Plowman, Watts, Robison, Tabor, Dion, Gaziano, Vu, & Gooch, 2016; Smith Hammond, 2001), 
a finding that is not surprising given the shared neural and anatomical substrates of respiration, 
cough, and swallowing function (Gestreau, 1996; Pitts, 2012; Troche, Brandimore, Godoy, & 
Hegland, 2014).  
Central pattern generators (CPGs) in the brainstem regulate the processes of eupnea 
(unlabored respiration), swallow, and cough (Davenport, Bolser, & Morris, 2011). The nucleus 
ambiguus, dorsal respiratory group, and ventral respiratory group located within the brainstem are 
associated with the neural control of the behaviors of respiration, cough, and swallow (Bolser, 
2002; Gestreau, 1996; Jean, 2001). Vagal afferent nerves that are both chemically and 
mechanically sensitive and non-myelinated c-fibers across multiple afferent beds (J.G., 1998) 
provide sensory feedback during swallowing (e.g. bolus volume consistency and volume, presence 
of aspirate material in the airway) which then informs the swallow central CPG (Pitts, 2012). The 
CPGs are inherently flexible in their connectivity to allow for rapid, on-line modification between 
the behaviors of cough, breathing, and swallowing such as, increasing apnea duration due to a 
larger swallowed bolus or the execution of a rapid and protective cough in response to aspirated 
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material during swallowing (Bianchi & Gestreau, 2009). Changes in respiratory muscle activation 
occur as the swallow CPG is informed about characteristics of the swallow (i.e., safe vs. unsafe, 
sequential vs. single sip) (Pitts, Rose, Mortensen, Poliacek, Sapienza, Lindsey, Morris, Davenport, 
& Bolser, 2013b). Higher order cortical processing or supramedullary input such as sensory 
integration and motor planning also provides vital input modulating both cough and swallowing 
behaviors. Computational modeling studies performed to determine neural networks of both cough 
and swallowing have elucidated shared efferent and afferent pathways involved for breathing, 
swallowing and cough (Davenport, Bolser, & Morris, 2011; Pitts, 2012).   
Evidence from human studies suggests that supramedullary input is involved in both 
voluntary and reflexive cough, with neural processing of stimuli prior to the act of cough resulting 
in what Davenport and colleagues (2008) have termed the “Urge to Cough” (Davenport, 2008; 
Davenport, Vovk, Duke, Bolser, & Robertson, 2009; Hegland K.W., 2011; Widdicombe, Eccles, 
& Fontana, 2006). This cortical regulatory component in humans is supported by the voluntary 
suppression of a reflexive cough response (Hegland K.W., 2011). In addition to the established 
shared central neurologic substrates, functions of respiration, swallow, and cough also peripherally 
share anatomical structures of the upper airway, pharynx, and oral and nasal cavities. Troche and 
colleagues (2014) conceptualized a framework for understanding the shared neural and anatomical 
substrates of cough and swallow in a comprehensive review on this topic (Troche, Brandimore, 
Godoy, & Hegland, 2014). This conceptual framework presents swallowing and cough along a 
‘spectrum of airway protective behaviors’, with swallowing at one end of the spectrum (protective 
function) and cough at the opposite end (defensive function) (Troche, Brandimore, Godoy, & 
Hegland, 2014). Thus, these two sensorimotor acts have highly coordinated and reciprocal 
functions with shared anatomical and neurologic underpinnings that provide a mechanistic, 
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anatomical and neurologic foundation for considering the role of cough during a clinical swallow 
examination.  
Clinical Swallowing Evaluation 
The main components of the CSE include a thorough medical history review; patient and 
caregiver interview of symptoms; physical inspection of the integrity of swallow anatomy at rest 
and during movement; and observation of performance on food and liquid swallowing trials 
(Logemann, 1984). The CSE is typically completed by a certified Speech-Language Pathologist 
(SLP) and performed across a variety of healthcare settings that include, but are not limited to: 
acute, sub-acute, and rehabilitation hospitals; specialized outpatient clinics’ skilled nursing homes; 
home health care; and assisted living facilities. The objective of the CSE is to obtain information 
from the patient’s history, self-reported symptoms and presenting clinical signs to make best 
clinical judgments regarding swallowing safety and efficiency and to provide dietary and treatment 
recommendations. The CSE plays an important role in patient care and it is critical to accurately 
identify patients who may have compromised swallow efficiency and airway safety. Dysphagia 
screening is typically implemented more broadly to asymptomatic patients in order to detect a 
possible condition (Suiter, 2012). At-risk patient groups (e.g. stroke) are often targeted for 
dysphagia screening.  
Given the previously identified limitations of the CSE to identify all individuals with 
dysphagia, and barriers to use, there exists a critical need for sensitive screening tools to be 
incorporated during the CSE (Mccullough, 2001; Plowman, Tabor, Robison, Gaziano, Dion, 
Watts, Vu, & Gooch, 2016; Plowman, Watts, Robison, Tabor, Dion, Gaziano, Vu, & Gooch, 
2016). Given the shared neurologic, anatomic and mechanic roles of cough and swallow, the 
potential utility of cough testing in the CSE has been a recent topic of interest to provide 
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information regarding mechanisms of airway safety and the physiologic ability of an individual to 
defend their airway (Pitts, Bolser, Rosenbek, Troche, & Sapienza, 2008; Pitts, Troche, Mann, 
Rosenbek, Okun, & Sapienza, 2010; Plowman, Watts, Robison, Tabor, Dion, Gaziano, Vu, & 
Gooch, 2016; Smith Hammond C.A. , 2001; Smith Hammond, Goldstein, Horner, Ying, Gray, 
Gonzalez-Rothi, & Bolser, 2009; Wheeler Hegland, Troche, Brandimore, Davenport, & Okun, 
2014). Currently, however, cough testing is not routinely incorporated in the CSE across all 
settings. There is substantial variability in current practice patterns in the evaluation of swallowing 
function (Mcallister, Kruger, Doeltgen, & Tyler-Boltrek, 2016). 
Validated Clinical Swallow Evaluations and Screening Tools 
Commonly utilized validated clinical swallow protocols include the: Barnes-Jewish 
Hospital Stroke Dysphagia Screen (BJH-SDS) (Edmiaston, Connor, Loehr, & Nassief, 2010; 
Edmiaston, Connor, Steger-May, & Ford, 2014); Mann Assessment of Swallowing Ability (Mann, 
2002); Modified Mann Assessment of Swallowing Ability (MMASA) (Antonios, Carnaby-Mann, 
Crary, Miller, Hubbard, Hood, Sambandam, Xavier, & Silliman, 2010); Toronto Bedside 
Swallowing Test (TOR-BSST) (Martino, Silver, Teasell, Bayley, Nicholson, Streiner, & Diamant, 
2009); Timed Swallow Test (Hinds, 1998); Acute Stroke Dysphagia Screen (ASDS) (Edmiaston, 
Connor, Loehr, & Nassief, 2010; Edmiaston, Connor, Steger-May, & Ford, 2014); Gugging 
Swallow Screen (GUSS) (Trapl, Enderle, Nowotny, Teuschl, Matz, Dachenhausen, & Brainin, 
2007); Yale Swallow Protocol (Suiter, Sloggy, & Leder, 2014); Volume Viscosity Test (Clave, 
Arreola, Romea, Medina, Palomera, & Serra-Prat, 2008); Northwestern Dysphagia Patient Check 
Sheet (Logemann, 1999); and the 3 oz. Water Swallow (Suiter & Leder, 2008). Table 1 provides 
a summary of these published, validated CSEs, with reference to the patient population the tool 
was validated for, tool administration, inclusion of cough testing, and any published statistical data 
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regarding its discriminant ability to identify dysphagia or unsafe swallowing.  
Of the 11 validated CSEs commonly used, 6 were designed to be administered specifically 
by Speech-Language Pathologists, 3 to be administered by trained nursing staff, and 1 by 
physicians (Logemann et al. did not specify). Review of published reports indicates that the highest 
levels of sensitivity (>85%) for detecting aspiration is provided by the BJH-SDS (Edmiaston, 
Connor, Loehr, & Nassief, 2010; Edmiaston, Connor, Steger-May, & Ford, 2014), Acute Stroke 
Dysphagia Screen (ASDS) (Edmiaston, Connor, Loehr, & Nassief, 2010; Edmiaston, Connor, 
Steger-May, & Ford, 2014), Yale Swallow Protocol (Suiter, Sloggy, & Leder, 2014), Volume 
Viscosity Test (Clave, Arreola, Romea, Medina, Palomera, & Serra-Prat, 2008), Northwestern 
Dysphagia Patient Check Sheet (Logemann, 1999), and the 3 oz. Water Swallow Test (Suiter & 
Leder, 2008). However, none of the protocols reach the highest level (>85%) of reported overall 
specificity for detecting aspiration. The Modified Mann Assessment of Swallowing Ability, a 
physician-administered protocol, provides the highest levels of sensitivity and specificity for 
detecting global swallowing impairment (i.e., 92% and 87% respectively).  
Of the 11 validated CSEs, 4 (36%) incorporate some form of cough testing. Description of 
cough testing methodology varies within the context of each examination. Upon careful inspection 
of the published protocols that include cough assessment, specific instructions for eliciting the 
cough task are vague, and the subjective perceptual measures of cough vary between protocols. 
The MMASA (same tasks as the MASA for cough testing) contains the most detailed instruction 
for cough elicitation and perceptual cough judgment. Per protocol, the physician or administrator 
asks the patient to ‘cough as strong as possible’ (Antonios, Carnaby-Mann, Crary, Miller, 
Hubbard, Hood, Sambandam, Xavier, & Silliman, 2010). Judgments of cough strength and clarity 
are rated, with an outcome score is assigned corresponding to one of the following: no abnormality, 
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cough attempted but is hoarse in quality, attempt inadequate, no attempt, or unable to perform. 
Logemann et al. (1999) described a subjective cough assessment in the Northwestern Dysphagia 
Patient Check Sheet, in which administrators judge either a voluntary cough, or throat-clearing 
maneuver, and perceptually rated the strength of the behavior. A strong cough/throat clear was 
judged as ‘safe’, and weak cough/throat clear was judged as ‘unsafe’ (Logemann, 1999). The 
GUSS includes an assessment of ‘voluntary cough’ without reference to specific cough task 
instruction; the cough task is rated based on a weak or absent response (Trapl, Enderle, Nowotny, 
Teuschl, Matz, Dachenhausen, & Brainin, 2007). 
Laciuga and colleagues recently investigated relationships between perceptual ratings of 
cough and objective airflow measures of cough (Laciuga, Brandimore, Troche, & Hegland, 2016). 
Thirty clinicians (speech- language pathologists, otolaryngologists and neurologists) rated the 
subjective parameters of strength, duration, quality, quantity, and overall ‘effectiveness’ of ten 
audio recordings of cough containing specific airflow characteristics. Objective physiological 
aerodynamic parameters of cough airflow were associated with the clinical perception of cough 
strength and effectiveness. The specific parameters that were clinically perceived as strong and 
effective included: compression phase duration, peak expiratory flow rate, peak expiratory flow 
rise time, cough volume acceleration and total expired volume. Interestingly, only 4 CSE protocols 
reviewed here currently utilize perceptual judgment of cough as part of the swallowing 
examination, and none include physiologic measures of cough airflow. 
Utility of Voluntary Cough Testing in Dysphagia  
Voluntary or volitional cough testing involves asking a patient to cough (typical 
instructions are: “as hard as you can” or “like have something stuck in their throat”). The resulting 
motor output can then be assessed either subjectively by listening, or objectively with specialized 
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equipment. For a complete review of the physiologic components of cough, we refer readers to 
Smith-Hammond et al. (ref number). Briefly, cough is characterized of three distinct phases:  
1) Inspiratory phase: composed of contraction of the external intercostal muscles elevating the 
anterior rib cage and drawing down the diaphragm as it contracts (West, 1995) while laryngeal 
muscle activation allows for passage of air through the glottis resulting negative pressure drawing 
air into the lungs (Bautista, Sun, & Pilowsky, 2012; West, 1995). 
2) Compression Phase: during which adduction of the vocal folds builds and maintains subglottic 
pressure generation. 
3) Expiratory Phase: composed of a forceful and rapid abduction of the vocal folds. Physiologic 
cough testing using the gold standard pneumotachograph measures airflow signals across all three 
phases that can be subsequently analyzed using specialized software. Objective cough flow 
measures can be derived and are illustrated in Figure 2.1 with definitions provided in Table 2.2. 
Several investigators have examined relationships between voluntary cough airflow 
measures and swallow safety status to elucidate the clinical utility of voluntary cough spirometry 
testing in several patient populations (Pitts, Bolser, Rosenbek, Troche, & Sapienza, 2008; 
Plowman, Watts, Robison, Tabor, Dion, Gaziano, Vu, & Gooch, 2016; Smith Hammond C.A. , 
2001; Smith Hammond, Goldstein, Horner, Ying, Gray, Gonzalez-Rothi, & Bolser, 2009).These 
are summarized in Table 2.3 and reviewed below. 
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Stroke 
Smith-Hammond and colleagues (2001) first examined the relationship between objective 
 
 
Figure 2.1 Example of voluntary cough waveform measured with cough spirometry. 
 
*Select derived objective measures are delineated on the waveform and referenced in Table 
2.2 including: A) inspiratory phase duration; B) inspiratory peak flow; C) compression phase 
duration; D) peak expiratory flow rate; and E) cough expired volume. Expiratory rise time is 
calculated by subtracting time at end of compression from peak expiratory flow time. Cough 
volume acceleration is not depicted but is calculated by dividing peak expiratory flow rate by 
the expiratory rise time. 
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Table 2.2. Definitions of objective voluntary cough airflow measures with reference to 
illustrative cough waveform depicted in Figure 2.1. Specific references of published studies 
utilizing each measure are also provided. 
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voluntary cough airflow measures and swallowing and noted significant relationships between 
expulsive rise times and aspiration status (p < 0.001) in 43 stroke patients (Smith Hammond, 
Table 2.3 Review of six research studies investigating the significant differences in voluntary 
cough measures between unsafe (penetrators and/or aspirators) and safe (non-aspirators) 
swallowers in dysphagic populations including Stroke, Parkinson’s disease, and Amyotrophic 
Lateral Sclerosis. 
 
Abbreviations: FEES: Fiberoptic Endoscopic Evaluation of Swallowing; PAS: Penetration-Aspiration Scale; 
VFSS: Videofluoroscopic Swallow Study; CP: cut point; AUC: area under the curve value; PPV: Positive 
predictive value, LR: Likelihood ratios 
 
First 
Author 
Year: 
Patient Population 
Number (N) Studied 
Swallowing Safety Groups: 
Swallowing Assessment 
Method  
and Testing Stimuli 
Statistical Comparison 
 
Significant Outcomes: Summary of Results 
 
 
Smith-
Hammond 
(2001) 
 
 
· Stroke 
· N = 43 Stroke; 18 control 
· Three airway safety 
groups: 
· Severe aspirators (asp’ 
on all bolus trials) 
· Mild aspirators (asp’ on 
one or two bolus 
consistencies) 
· Non-Aspirators (no asp’ 
across trials) 
· VFSS or FEES (group n is 
not specified) 
· 5mL, 15 mL, and unregulated 
cup sips of thin liquid, Ensure 
Plus, and ‘thickened	liquid’	
(250-300	cP).	(Liquid	
prepared	to	match	available	
drinks	to	inpatients).	
· Between groups comparison 
(severe aspirators vs. non-
aspirators) 
      
 
Severe aspirators (vs. non-aspirators) demonstrated:  
· Lower peak inspiratory flow rate (770.60 vs. 1,120 
mL/s) 
· Lower peak expiratory flow rate (-875.13 vs. -
1,884.14 mL/s) 
· Higher expiratory rise times (0.34 vs. 0.09 sec) 
· Lower cough volume acceleration (5.49 vs. 27.84 
mL/s/s) 
Pitts 
(2008) 
· Parkinson’s disease  
· N = 20 
· Safe: PAS score 1  
· Unsafe: PAS score 2-8 
 
· VFSS 
· 30mL liquid 
· Between groups comparison 
(safe vs. unsafe) 
        
PD patients with unsafe PD swallowing demonstrated: 
· Longer compression phase durations (0.36 vs. 0.16 
sec) 
· Higher expiratory rise times (0.41 vs. 0.21 sec) 
· Lower peak expiratory flow rate (6.17 vs. 8.94 L/s) 
· Lower cough volume acceleration (17.02 vs. 45.24 
L/s/s) 
Smith-
Hammond 
(2009) 
· Stroke 
· N = 96 
· Non-aspirators: PAS 
score 1-4 
· Aspirators: PAS score 5-
8 
· VFSS (n = 91) or FEES (n = 
5) 
· Pearson correlation 
coefficient to determine 
associations between 
aspiration risk (PAS ≥ 5) and 
objective cough measures  
Stroke patients who aspirated demonstrated: 
· Lower inspiration phase volume (0.45 vs. 0.69 L) 
· Lower inspiration peak flow (-0.82 vs. -1.44 L/s) 
· Lower peak expiratory flow rate (1.98 vs. 5.62 L/s) 
· Higher expiratory rise times (161.50 vs. 14.05 ms) 
· Lower cough volume acceleration (23.49 vs. 136.15 
L/s/s) 
Pitts 
(2010) 
· Parkinson’s disease  
· N = 58 
· Safe: PAS score 1  
· Unsafe: PAS score 2-8 
 
· VFSS 
· 30mL liquid 
· Receiver operator 
characteristic analysis  
Discriminant ability of voluntary cough airflow 
measures to detect penetration/aspiration: 
· Compression phase duration: CP: 0.2 s, sensitivity: 
95.8%, specificity: 64.7%, LR: 2.7, AUC: 0.83 
· Expiratory phase rise time: CP: 70.8 ms, sensitivity: 
70.8%, specificity: 64.7%, LR: 2.7, AUC: 0.71 
· Expiratory phase peak flow: CP: 7.5 L/s, sensitivity: 
87.5%, specificity: 50%, LR: 1.8, AUC: 0.69 
· Cough volume acceleration: CP: 84.5 s/s, sensitivity: 
54.5%, specificity: 97.1%, LR: 18.4, AUC: 0.72 
Hegland 
(2014) 
· Parkinson’s disease  
· N = 40 
· Safe: PAS score 1-2 
· Unsafe: PAS score 3-8 
· VFSS 
· ~5mL thin liquid; cup sip thin 
liquid; two sequential sips 
thin liquid; spoon-sized 
pudding bolus; cookie coated 
in barium 
· Between groups comparison 
among cough parameters and 
penetrator/aspirator vs. non-
P/A 
 On the first cough of the epoch, PD patients with safe 
vs. unsafe (PAS≥4) swallowing demonstrated:  
· Longer compression phase durations (0.45 vs. 0.22 
s) 
· Lower peak expiratory flow rates (5.51 vs. 4.19 L/s) 
· Lower amount of air expired during the sequential 
cough (49 vs. 42%) 
 
 
 
Plowman 
(2016) 
 
 
· Amyotrophic Lateral 
Sclerosis 
· N = 70  
· Safe: PAS score 1-2  
· Unsafe: PAS score 3-8 
 
 
 
· VFSS 
· 20mL liquid 
· Between group comparisons 
and receiver operator 
characteristic analysis. 
Unsafe ALS patients demonstrated: 
· Lower cough volume acceleration (33.21 vs. 103.71 
L/s/s) 
· Longer peak expiratory rise times (159.20 vs. 78.80 
ms) 
· Lower peak expiratory flow rate (2.88 vs. 5.31 L/s) 
Discriminant ability of voluntary cough airflow 
measures to detect penetration/aspiration: 
· Cough volume acceleration: CP: 45.3s/s, sensitivity: 
91.3%, specificity: 82.2%, LR: 5.1, AUC: 0.85 
· Expiratory rise time: CP: 80 ms, sensitivity: 82.6%, 
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2001). Subsequently Smith-Hammond et al. (Smith Hammond, Goldstein, Horner, Ying, Gray, 
Gonzalez-Rothi, & Bolser, 2009) expanded these preliminary findings in a larger cohort of 96 
stroke patients who underwent cognitive testing, a CSE, voluntary cough spirometry testing, cough 
sound pressure level testing (dB SPL), and an instrumental swallow evaluation (either FEES or 
VFSS). Swallow safety status was objectively defined using the Penetration-Aspiration Scale 
(PAS) score (Smith Hammond, Goldstein, Horner, Ying, Gray, Gonzalez-Rothi, & Bolser, 2009), 
with participant groups delineated into non-aspirators (PAS > 4) vs. aspirators (PAS ≥ 5). Clinical 
indications such as absent swallow initiation, difficulty with secretions, and elicitation of post-
prandial reflexive cough had an overall sensitivity of 53% and specificity of 83%, indicating poor 
sensitivity and moderate specificity in relation to the clinical assessment measures. Acoustic cough 
testing demonstrated clinical utility, with mean cough sound-pressure levels significantly lower in 
aspirators compared to non-aspirators (83.7 vs. 96.4 dB SPL; p < 0.0001). There were significant 
differences in several cough airflow measures between the groups. Specifically, non-aspirators 
demonstrated lower inspiration phase volume (0.45 vs. 0.69 L; p < 0.05), inspiration peak flow  
(-0.82 vs. -1.44 L/s; p < 0.0001), peak expiratory flow rate (1.98 vs. 5.62 L/s; p < 0.0001), higher 
expiratory rise times (161.50 vs. 14.05 ms; p < 0.0001), and lower cough volume acceleration 
(23.49 vs. 136.15 L/s/s; p < 0.0001). These authors concluded that, in addition to instrumental 
swallowing assessment techniques, objective measures of voluntary cough spirometry may be 
useful in identifying airway safety status in individuals post stroke (Smith Hammond, Goldstein, 
Horner, Ying, Gray, Gonzalez-Rothi, & Bolser, 2009).  
Parkinson’s disease 
Pitts et al. (2008) first documented relationships between voluntary cough airflow 
measures and swallowing airway safety status in 20 individuals with Parkinson’s disease (PD). 
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Unsafe PD swallowers (PAS > 2) demonstrated longer compression phase durations (0.36 vs. 
0.16s; p < 0.001), longer peak expiratory rise times (0.41 vs. 0.21s; p < 0.001), lower peak 
expiratory flow rates (6.17 vs. 8.94 L/s; p < 0.001), and lower cough volume accelerations (17.02 
vs. 45.24 L/s/s; p < 0.001).  
In a larger follow-up investigation, Pitts and colleagues (Pitts, Troche, Mann, Rosenbek, 
Okun, & Sapienza, 2010) evaluated the discriminant ability of voluntary cough airflow measures 
for detecting unsafe swallowing in 58 individuals with PD. Results of this work indicated that the 
same four cough measures reported to be different in their earlier study demonstrated good 
discriminant ability to detect unsafe PD swallowers (Pitts, Troche, Mann, Rosenbek, Okun, & 
Sapienza, 2010). 
Hegland et al. (2014) most recently demonstrated that sequential voluntary cough is 
associated with airway safety status in individuals with PD (Hegland, Okun, & Troche, 2014). 
Airflow measures were recorded and objective cough spirometry measures, including percent 
cough expired volume (%CEV), were obtained across two trials of sequential voluntary coughs. 
Significant differences between safe (PAS < 2) vs. unsafe (PAS > 3) swallowing groups were 
noted for: compression phase duration, expiratory peak flow, and percent cough expired volume 
(p < 0.05). PD patients with safe swallowing demonstrated coughs with higher peak expiratory 
flow rates, cough volume acceleration, and percent cough expired volume (i.e. significantly 
different in the first and third expiratory effort). Further, Hegland and colleagues noted that 
differences in cough-expired volumes between safe and unsafe swallow groups provided evidence 
of uncoordinated sequential cough patterns in the unsafe swallow PD subjects (Hegland, Okun, & 
Troche, 2014).  
Amyotrophic Lateral Sclerosis 
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 Plowman et al. (Plowman, Watts, Robison, Tabor, Dion, Gaziano, Vu, & Gooch, 2016) 
studied voluntary cough spirometry airflow measures and airway safety status in 70 individuals 
with amyotrophic lateral sclerosis (ALS). Participants completed both voluntary cough airflow 
testing and a VFSS and were grouped into safe (PAS ≤ 2) or unsafe (PAS ≥ 3) ALS swallowers. 
Similar to findings in stroke and PD patient populations, significant differences were observed 
across a number of measures. ALS patients with unsafe swallowing demonstrated lower cough 
volume acceleration (33.21 vs. 103.71 L/s/s, p = 0.00001), longer peak expiratory rise times 
(159.20 vs. 78.80 ms, p = 0.003), and lower peak expiratory flow rates (2.88 vs. 5.31 L/s, p = 
0.00005). Further, these three expiratory phase measures showed a good discriminant ability to 
detect the presence of penetration and/or aspiration (see Table 2.3 for full results) (Plowman, 
Watts, Robison, Tabor, Dion, Gaziano, Vu, & Gooch, 2016). Sensitivity and specificity were 
highest for cough volume acceleration (91.3 and 82.2% respectively) and ALS patients whose 
cough volume acceleration was below 45.28L/s/s were 5.12 times more likely to penetrate/aspirate. 
These authors concluded that impairment in the expiratory phase of voluntary cough may be 
related to degeneration of laryngeal, respiratory, and upper aerodigestive tract musculature, which 
compromises the ability to build ballistic force generation needed for an effective expiration phase 
(Plowman, Watts, Robison, Tabor, Dion, Gaziano, Vu, & Gooch, 2016). Recommendations were 
made for the consideration of cough-flow testing in the clinical screening of individuals with ALS 
and the use of their published cut points as references when considering airway safety risk status 
(Plowman, Watts, Robison, Tabor, Dion, Gaziano, Vu, & Gooch, 2016). 
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Table 2.3 Review of six research studies investigating the significant differences in voluntary 
cough measures between unsafe (penetrators and/or aspirators) and safe (non-aspirators) 
swallowers in dysphagic populations including Stroke, Parkinson’s disease, and Amyotrophic 
Lateral Sclerosis. 
 
 
Abbreviations: FEES: Fiberoptic Endoscopic Evaluation of Swallowing; PAS: Penetration-Aspiration Scale; 
VFSS: Videofluoroscopic Swallow Study; CP: cut point; AUC: area under the curve value; PPV: Positive predictive 
value, LR: Likelihood ratios 
 
 
These studies, across three different neurogenic patient populations, highlight the potential 
utility of voluntary cough assessment during the clinical evaluation of swallowing. Several 
First 
Author 
(Year) 
Patient Population 
Number (N) Studied 
Swallowing Safety 
Groups: 
Swallowing Assessment 
Method 
and Testing Stimuli 
Statistical Comparison: 
 
Significant Outcomes: Summary of Results 
 
 
Smith-
Hammond 
(2001) 
 
 
· Stroke 
· N = 43 Stroke; 18 
control 
· Three airway safety 
groups: 
· Severe aspirators (asp’ 
on all bolus trials) 
· Mild aspirators (asp’ 
on one or two bolus 
consistencies) 
· Non-Aspirators (no 
asp’ across trials) 
· VFSS or FEES (group n is 
not specified) 
· 5mL, 15 mL, and 
unregulated cup sips of 
thin liquid, Ensure Plus, 
and ‘thickened liquid’ 
(250-300 cP). (Liquid 
prepared to match 
available drinks to 
inpatients). 
· Between groups 
comparison (severe 
aspirators vs. non-
aspirators) 
      
 
Severe aspirators (vs. non-aspirators) demonstrated:  
· Lower peak inspiratory flow rate (770.60 vs. 1,120 
mL/s) 
· Lower peak expiratory flow rate (-875.13 vs. -
1,884.14 mL/s) 
· Higher expiratory rise times (0.34 vs. 0.09 sec) 
· Lower cough volume acceleration (5.49 vs. 27.84 
mL/s/s) 
Pitts 
(2008) 
· Parkinson’s disease  
· N = 20 
· Safe: PAS score 1  
· Unsafe: PAS score 2-8 
 
· VFSS 
· 30mL liquid 
· Between groups 
comparison (safe vs. 
unsafe) 
        
PD patients with unsafe PD swallowing demonstrated: 
· Longer compression phase durations (0.36 vs. 0.16 
sec) 
· Higher expiratory rise times (0.41 vs. 0.21 sec) 
· Lower peak expiratory flow rate (6.17 vs. 8.94 L/s) 
· Lower cough volume acceleration (17.02 vs. 45.24 
L/s/s) 
Smith-
Hammond 
(2009) 
· Stroke 
· N = 96 
· Non-aspirators: PAS 
score 1-4 
· Aspirators: PAS score 
5-8 
· VFSS (n = 91) or FEES (n 
= 5) 
· Pearson correlation 
coefficient to determine 
associations between 
aspiration risk (PAS ≥ 5) 
and objective cough 
measures  
Stroke patients who aspirated demonstrated: 
· Lower inspiration phase volume (0.45 vs. 0.69 L) 
· Lower inspiration peak flow (-0.82 vs. -1.44 L/s) 
· Lower peak expiratory flow rate (1.98 vs. 5.62 L/s) 
· Higher expiratory rise times (161.50 vs. 14.05 ms) 
· Lower cough volume acceleration (23.49 vs. 136.15 
L/s/s) 
Pitts 
(2010) 
· Parkinson’s disease  
· N = 58 
· Safe: PAS score 1  
· Unsafe: PAS score 2-8 
 
· VFSS 
· 30mL liquid 
· Receiver operator 
characteristic analysis  
Discriminant ability of voluntary cough airflow measures 
to detect penetration/aspiration: 
· Compression phase duration: CP: 0.2 s, sensitivity: 
95.8%, specificity: 64.7%, LR: 2.7, AUC: 0.83 
· Expiratory phase rise time: CP: 70.8 ms, sensitivity: 
70.8%, specificity: 64.7%, LR: 2.7, AUC: 0.71 
· Expiratory phase peak flow: CP: 7.5 L/s, sensitivity: 
87.5%, specificity: 50%, LR: 1.8, AUC: 0.69 
· Cough volume acceleration: CP: 84.5 s/s, sensitivity: 
54.5%, specificity: 97.1%, LR: 18.4, AUC: 0.72 
Hegland 
(2014) 
· Parkinson’s disease  
· N = 40 
· Safe: PAS score 1-2 
· Unsafe: PAS score 3-8 
· VFSS 
· ~5mL thin liquid; cup sip 
thin liquid; two sequential 
sips thin liquid; spoon-
sized pudding bolus; 
cookie coated in barium 
· Between groups 
comparison among cough 
parameters and 
penetrator/aspirator vs. 
non-P/A 
 On the first cough of the epoch, PD patients with safe vs. 
unsafe (PAS≥4) swallowing demonstrated:  
· Longer compression phase durations (0.45 vs. 0.22 s) 
· Lower peak expiratory flow rates (5.51 vs. 4.19 L/s) 
· Lower amount of air expired during the sequential 
cough (49 vs. 42%) 
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limitations exist, however, regarding the practical implementation of such testing protocols. First, 
the equipment required to perform such testing is expensive and likely cost-prohibitive in most 
clinical settings. Second, specialized software and training of personnel is required to analyze 
cough waveforms and the analyses are labor and time intensive. Finally, this equipment is not 
easily portable, posing a barrier to access in certain patient populations. A potential alternative to 
the gold standard pneumotachograph airflow testing techniques utilized in the aforementioned 
studies is the use of a hand-held digital, or analogue, peak cough flow meter capable of measuring 
peak cough flow (L/s) and forced expiratory volume (FEV1, L) in real time without the need for 
waveform analysis or cost-prohibitive equipment. Indeed, Silverman et al. (Silverman, Carnaby-
Mann, Pitts, Davenport, Okun, & Sapienza, 2014) recognized this need and studied the 
concordance of several handheld digital and analog peak cough flow devices to quantify peak 
cough airflows compared to the gold-standard pneumotachograph method. Silverman et al 
(Silverman, Carnaby-Mann, Pitts, Davenport, Okun, & Sapienza) indicated that both digital and 
analog devices (the Mini Wright peak flow meter, and Mini Wright digital peak flow meter) 
demonstrated good concordance with the gold standard method for measuring peak cough flow in 
healthy males and older female PD patients. The analog peak airflow device was reported to 
demonstrate a higher level of concordance for cough strength in both healthy and disease states 
(Silverman, Carnaby-Mann, Pitts, Davenport, Okun, & Sapienza, 2014). It is important to note, 
however, that these devices do not provide the detailed measurement parameters offered by cough 
spirometry testing. Additionally, there is contraindicating evidence that documents poor agreement 
between portable peak flow meter readings and the peak cough flow as measured by the gold 
standard physiologic assessment (i.e., pneumotachograph) (Kulnik, Macbean, Birring, Moxham, 
Rafferty, & Kalra, 2015). Further research is necessary to determine the validity of voluntary 
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cough testing using such handheld devices in several patient populations and healthy controls. 
An additional consideration regarding the utility of voluntary cough testing in the 
evaluation of swallowing function is the fact that evaluating a volitional cough (i.e. asking a patient 
to cough) does not provide direct information on the nature of a protective cough response to 
aspirated material during swallowing (i.e. triggered by afferent stimuli in the airway). 
Additionally, voluntary cough production is highly dependent on instruction. That is, airflow 
patterns and perceived “strength” of a cough has been noted to change in a graded manner based 
upon the instruction provided (Davenport, 2008). A testing method that more closely models an 
airway protective cough response is the reflexive cough testing method, and will be discussed next. 
Reflexive or Induced Cough Testing  
Another method of testing cough is to perform reflexive cough testing to induce or elicit a 
cough response and measure response profiles. Using this method, an individual inhales an 
aerosolized irritant such as capsaicin, citric acid aerosols, fog, tartaric acid, acetic acid, or 
hypertonic solutions (Fontana & Widdicombe, 2007) that can be delivered at different 
concentrations through a nebulizer or facemask. A patient’s response profile can then be measured 
and their cough threshold determined and compared to normative values. Outcomes can be as 
simple as a binary measure (present / absent cough response) or airflow parameters can be 
measured using the cough spirometry techniques previously discussed. In addition to measuring 
the motor output of the cough response, the afferent aspect of this sensorimotor behavior can be 
probed by asking the patient their perceived ‘Urge to Cough’ using a modified Borg scale across 
each cough trial (Davenport, 2008). Cough output is affected by irritant type, concentration, 
volume and duration of exposure, order of presentation, placebo trials, nasal afferent stimulation, 
and lung volume at the start of cough initiation (Troche, Brandimore, Godoy, & Hegland, 2014). 
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These variables impact cough flow rates, number of coughs produced, urge to cough (self-report), 
amplitude and duration of expiratory muscle activation, and time to initiation of a cough response 
(Troche, Brandimore, Godoy, & Hegland, 2014). Similar to voluntary cough testing, several 
investigators have examined the potential discriminant ability of reflexive cough testing in 
determining swallowing safety status, which will now be highlighted. A summary of these studies 
is provided in Table 2.4. 
Table 2.4 Summary of published reports investigating the discriminant ability of reflexive 
cough testing to detect swallowing safety. 
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Abbreviations: FEES: Fiberoptic Endoscopic Evaluation of Swallowing; NPV: Negative predictive value; OR: Odds 
ratio; PAS: Penetration Aspiration Scale; PPV: Positive predictive value; SCT: Simplified Cough Test (reflexive 
cough test); VFSS: Videofluoroscopic Swallow Study. 
*Heterogeneous sample Sato (2012) included 141 consecutive patients; 89 individuals post stroke, 22 disuse 
syndrome, 8 neuromuscular, 14 respiratory, 3 cancer, 2 cervical spine injury, 3 miscellaneous. Neuromuscular 
disease included Parkinson’s disease, corticobasal degeneration, multiple systems atrophy, and spinocerebellar 
degeneration. Miles (2013) included Stroke, Head and neck cancer, respiratory, progressive neurological, other 
neurological, and other. 
∞Binary classification based on total number of coughs produced was as follows: “responders” were defined as those 
who produced at least 2 coughs on 2/3 trials for each irritant type independently (fog and capsaicin). 
** Positive cough response defined as two or more consecutive coughs triggered. 
 Sato et al. (2012) evaluated 141 consecutively referred patients with non-specific 
complaints of dysphagia. Primary medical diagnoses included stroke, neuromuscular disease, 
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deconditioning, respiratory disease, cancer, cervical spinal injury, and ‘miscellaneous.’ FEES 
was used to determine airway safety status, yielding 53 unsafe swallowers (aspirators) and 88 
safe swallowers (no aspiration). Reflex cough testing was performed using a citric acid-saline 
solution [1% weight/volume (w/v)] to induce a reflexive cough with time from citric-acid 
administration to elicitation of the first cough the primary metric of interest. Results indicated 
that time to first cough demonstrated excellent discriminant ability for identifying silent 
aspirators in this cohort. Specifically, a value of 30 seconds post-irritant administration to the 
first cough demonstrated a sensitivity and specificity for detection of silent aspiration of 92% and 
94%, respectively. When including all aspirators, however, a cutoff of 60 seconds for cough 
reaction time yielded a sensitivity and specificity for detection of aspiration at 81% and 65%. 
These results suggest that subtle differences in cough reaction time affects the accuracy of 
detecting silent aspiration. 
Miles at al. (2013) examined the utility of reflexive cough testing for identification of silent 
aspiration in 181 consecutively referred inpatients with diagnoses including stroke, head and neck 
cancer, ‘respiratory disease,’ progressive neurologic disease, and ‘other.’ All individuals were 
evaluated with reflexive cough testing and an instrumental swallowing evaluation (either FEES or 
VFSS). Swallowing safety status was determined by a blinded SLP who rated either the FEES or 
VFSS using the PAS scale and patients were grouped by: no aspiration, aspiration with cough (not 
specified if it was an effective cough), trace silent aspiration, and silent aspiration 
Cough thresholds were evaluated using randomly administered citric acid solutions (0.4 
mol/L, 0.6 mol/L, 0.8 mol/L, and placebo) via facemask nebulizer on a continuous flow. The 
primary outcome measure was presence or absence of cough following each 15-second interval. 
The trial was considered a “positive” response and if the patient coughed two or more times at a 
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given concentration. Additionally, researchers perceptually rated subjective cough response 
strength (weak or strong). The concentration of 0.6 mol/L was shown to have the highest level of 
accuracy for discriminating between safe and unsafe swallowers on the VFSS (sensitivity of 71%, 
specificity of 60%). However, these values are considered below ideal for a good screening tool.  
More recently, Hegland et al. (2016) investigated cough response profiles to varied irritant 
types in both healthy controls and individuals with PD. Patients underwent VFSS and were 
categorized into safe (non-aspirators, PAS ≤ 4) vs. unsafe (aspirators, PAS ≥ 5) swallowing groups. 
Irritant stimuli included diluted capsaicin (200μM dissolved in vehicle solution of 80% 
physiologic saline and 20% ethanol) and aerosolized water (fog). Both irritants were delivered 
through a nebulizer (Omron Micro-Air NE U22 V, Tokyo, Japan) for 60 seconds and the mean 
number of coughs produced within a 30 second time-frame and categorical ‘responders’ and ‘non-
responder’ data was collected. For binary responder/non-responder outcomes, there were 
differences in response to irritant type with regards to the sensitivity and specificity for detecting 
laryngeal penetration and/or aspiration. Specifically, capsaicin yielded a sensitivity of 44.4% and 
specificity of 100% and fog a sensitivity of 77.8% and specificity of 90.9%. Additionally, there 
were significant differences in the number of coughs produced between safe and unsafe 
swallowers, with unsafe swallowers producing fewer coughs to both fog and capsaicin.  
Hegland and colleagues reported poor sensitivity (20%) but good specificity (95.9%) for 
detecting unsafe swallowing with reflexive cough testing (using capsaicin) in PD (Hegland, 
Troche, Brandimore, Okun, & Davenport, 2016) and concluded that the high false negative (not 
detecting an impairment) may indicate that the single inhalation may not be the correct 
methodology to implement to rule out aspiration in this population. The authors also reported that 
a difference in response to fog vs. capsaicin suggests possible differences in neural control of 
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cough regulation. 
Kallesen et al. (Kallesen, Psirides, & Huckabee, 2016) investigated the clinical utility of 
reflexive cough testing for assessment of swallowing impairment in 106 recently extubated 
intensive care unit patients (Kallesen, Psirides, & Huckabee, 2016). Patients underwent FEES 
evaluation and reflexive cough testing with concentrations of 0.4, 0.6, and 0.8 mL/L nebulized 
citric acid mixed with 0.9% sodium within 24 hours of extubation. The PAS was used to 
differentiate penetrators (PAS < 5) vs. aspirators (PAS ≥ 6), yielding 13 aspirators, 9 of which 
were identified as silent aspirators (69%). Concentrations of 0.4, 0.6, and 0.8 mL/L demonstrated 
sensitivity values of 100%, 100%, and 88% and a specificity of 42%, 49%, and 58% for detecting 
aspiration, respectively. Kallesen and colleagues concluded that reflex cough testing over-
identified aspiration in this patient population. 
Multiple variables can be manipulated when performing reflexive cough testing and thus, 
may result in drastically different patient responses. These studies highlight the potential utility of 
reflexive cough evaluation for the assessment of aspiration status and also provide complimentary 
literature to the voluntary cough testing. Cough reflex testing methodology may be more practical 
as part of a screening assessment as the methodology is inexpensive, quick to administer, and 
objective outcomes relatively simple to interpret. However, the lack of consensus for testing 
protocols and scarce data in multiple patient populations highlight an important gap in the 
literature. This leads to the inability to provide cohesive practice recommendations in regards to 
the optimal irritant type and strength of solution, length of delivery, and outcome measures. 
Although these articles provide an excellent foundation, more research is warranted to provide 
guidelines to practicing clinicians.  
Limitations and Future Directions 
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Although an emerging and promising dataset supports the use of cough testing in the 
clinical evaluation of swallowing, current data is limited and restricted to only a few patient 
populations with a critical need for more data to validate these promising findings in other patient 
populations. Practical limitations of objective voluntary cough testing procedures necessitate the 
need for further studies to examine the discriminant ability of simple and inexpensive cough testing 
using handheld peak-flow meters, similar to the work of Silverman and colleagues (Silverman, 
Carnaby-Mann, Pitts, Davenport, Okun, & Sapienza, 2014). Reflexive cough testing represents a 
relatively simple, inexpensive and relatively quick method of testing that is currently being utilized 
clinically by Dr. Karen Hegland in a busy clinic for individuals with Parkinson’s disease, with 
binary cough threshold testing and urge to cough screens performed routinely at every patient visit 
(Hegland, personal communications).   
Conclusions 
This narrative review highlights the shared neural and anatomical substrates mediating 
cough and swallowing, as well as the co-occurring presence of dystussia and dysphagia. 
Additionally, the role of cough in defending the airway and rationale for providing a physiologic 
index of airway defense in patients at risk for dysphagia has been delineated. A small but growing 
body of literature supports the inclusion of cough testing in the CSE to provide an index of overall 
function and capacity of airway defense mechanisms to aide in clinical and diagnostic decision-
making and assessment of potential risk of impairments in swallowing safety. Clearly more data 
are needed to validate these findings, in addition to using practical, inexpensive and efficient 
methods that can be easily implemented in busy clinical settings to provide valid and reliable 
results across practice settings.   
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CHAPTER THREE 
 
CURRENT PRACTICE PATTERNS 
Introduction 
Dysphagia is a symptom of underlying disease and unfortunately, associated with a variety 
of medical diagnoses. Dysphagia adversely impacts health status, quality-of-life (QOL), and 
creates financial burden for patients and their caregivers (Cichero, 2012; Leow, Huckabee, 
Anderson, & Beckert, 2010; Maclean, Cotton, & Perry, 2009). When evaluating the swallowing 
process, it is critical to incorporate assessment of airway safety status, bolus efficiency, and airway 
protective ability (i.e., cough). Impairments in these domains often lead to pulmonary sequela, and 
undernourishment (Guest, Panca, Baeyens, De Man, Ljungqvist, Pichard, Wait, & Wilson, 2011). 
Pulmonary infection also termed, aspiration pneumonia, has been identified as the leading cause 
of death Parkinson’s disease (PD) and the elderly (Fernandez & Lapane, 2002; Gorell, Johnson, & 
Rybicki, 1994; Hely, Reid, Adena, Halliday, & Morris, 2008; Marik & Kaplan, 2003; Shill & 
Stacy, 1998).  Further, malnutrition has been associated with oropharyngeal dysphagia in the 
geriatric population, (Cabre, Serra-Prat, Force, Almirall, Palomera, & Clave, 2014; Chapman, 
2006; Namasivayam-Macdonald, Morrison, Steele, & Keller, 2017) and increases the risk of death 
in individuals with amyotrophic lateral sclerosis (ALS) (Chio, Logroscino, Hardiman, Swingler, 
Mitchell, Beghi, Traynor, & Eurals, 2009; Serra-Prat, Palomera, Gomez, Sar-Shalom, Saiz, 
Montoya, Navajas, Palomera, & Clave, 2012). Timely identification of swallowing impairment 
and reduced ability to protect the airway is vital to ensure implementation of management 
strategies to optimize oral intake and maintain pulmonary health and patient QOL.  
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Physicians, nurses, and speech-language pathologists (SLP) who hold a certificate of 
clinical competency (CCC-SLP) perform clinical swallow assessments (CSE) across a variety of 
health care settings hospitals and skilled nursing facilities (Association, 2000; Logemann, 1998). 
Regardless of the practitioner, an individual may only have five to fifteen minutes to determine a 
patient’s swallow safety status. The accuracy of clinical swallow evaluation techniques and 
assessment capabilities of airway protective behaviors vary widely (Daniels, Anderson, & Willson, 
2012; Leder, Suiter, Murray, & Rademaker, 2013; Mathers-Schmidt & Kurlinski, 2003). CSE 
components may include: review of case history, cranial nerve assessment, clinical feeding trials 
of various bolus consistencies, and a voice quality assessment (McCullough, Wert, Rosenbek 
2001, McCullough, Rosenbek, Wertz, McCoy, Mann, McCullough, 2005, Daniels, Anderson, 
Willson, 2012). However, a recent study has shown that SLPs prioritize clinical skills and 
reasoning above following an outlined checklist assessment method such as item-based protocols 
(Mcallister, Kruger, Doeltgen, & Tyler-Boltrek, 2016). 
Of late, there is increasing evidence indicating the usefulness of gold standard voluntary 
cough using spirometry to determine airway safety status (Pitts, Bolser, Rosenbek, Troche, & 
Sapienza, 2008; Pitts, Troche, Mann, Rosenbek, Okun, & Sapienza, 2010; Plowman, Watts, 
Robison, Tabor, Dion, Gaziano, Vu, & Gooch, 2016; Smith Hammond, Goldstein, Horner, Ying, 
Gray, Gonzalez-Rothi, & Bolser, 2009; Smith Hammond, 2001; Troche, Okun, Rosenbek, 
Musson, Fernandez, Rodriguez, Romrell, Pitts, Wheeler-Hegland, & Sapienza, 2010). However, 
instrumental voluntary cough testing methods remain outside of current CSE published guidelines. 
With the addition of quality literature over the past decade regarding relationships between cough 
and swallow, it remains is unclear if subjective assessment of voluntary cough sound is widely 
used in clinical practice, and/or what aspects of cough are being considered as clinically useful. 
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The lack of insight into current practice patterns of voluntary cough assessment limits the 
usefulness of research on optimization of cough techniques that are easily implemented in the 
clinical settings. Consequently, the aim of the current investigation is to define current practices 
for subjective voluntary cough assessment during the CSE. Based on limited clinical practice 
guidelines for cough testing and limited inclusion of cough testing methods included in CSE’s, it 
is hypothesized that across a variety of medical settings that subjective assessment of cough sound 
is not routinely implemented despite years of training or clinical experience.  
Methods 
Participants  
SLPs and other medical professionals who currently assess swallowing were targeted to 
complete an online survey via forum post on two professional organization sites: American Speech 
Language Hearing Association (ASHA) special interest group 13 (swallowing and swallowing 
disorders) and Dysphagia Café. A total of 781 individuals responded to the survey. This study 
received approval by the University of South Florida Institutional Review Board (#00017474) (see 
Appendix B) and all participants provided consent via an online questionnaire prior to the initiation 
of the survey.    
Materials and Procedures 
Qualtrics online survey software was used to construct, disseminate, and store acquired 
survey data (Qualtrics; Provo, UT). The pilot survey included 22 questions divided into two 
sections: 1) demographic information; and 2) bedside swallow evaluation practices with specific 
reference to cough testing. Questions regarding perceptual cough assessments allowed for free text 
answers for trend analysis. In addition, survey construction was designed to reduce participant 
bias. Field-testing of the pilot survey included review of each item for relevance, mutually 
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exclusivity, and clinical significance. There were a total of 18 remaining questions following field-
testing (please see Appendix C to view the final constructed survey questions). 
The electronic survey format, Qualtrics, allowed for the use of “skip logic.” Certain 
questions were revealed to the participant based on response to a prior question. For example, if 
the participant answered “no” to the question, “Are you a Speech Language Pathologist (SLP)?” 
the question, “What is your SLP certification level?” was skipped. Mandatory responses (14 in 
total) were deemed as responses that must be completed despite skip logic. These are denoted in 
Appendix C. 
Participants had access to the survey for a total of three months. A two-tier elimination 
process was utilized to evaluate for completed and appropriate responses. First, given that the 
survey was related to CSE practice patterns, participants who responded “no” to “do you conduct 
clinical swallow examinations?” or left the response blank were excluded. This exclusion resulted 
in resulted in 722 valid responses. Lastly, mandatory responses (items displayed regardless of skip 
logic) were tabulated; participants who completed <85% of mandatory responses were excluded, 
this resulted a total of 605 survey responses used for analysis.  
Statistical Analysis 
Survey responses were analyzed using descriptive and associative methods. A Chi-square test 
statistic was used to determine if there was a significant difference in voluntary cough assessment 
patterns between certification level and years of experience. This was chosen because the nominal 
data was derived from a random sample, the sample groups were independent of one another and 
observations within the sample groups were independent of one another (i.e., respondents were in 
one category or another). Binary and categorical data were summarized as frequencies. Open 
question responses were analyzed based on thematic content and grouped according to theme. Data 
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is presented as mean ± standard deviation (SD), and significance was set at p < 0.05.  
 
Results 
Participant Demographics 
Following the two-tier elimination process to include appropriate and complete responses, 
605 out of 781 (77%) survey responses were analyzed for this study, representing 48 states and 1 
United States territory represented (see Figure 3.1). Of the 605 participants, 505 were from the 
United States of America, 24 were from Canada, and 76 were from outside of North America. 
Table 3.1 contains full respondent demographics. The total mean time to complete the survey was 
11.7 ± 59 minutes. 
 
 
 
 
Figure 3.1 Color illustrative map of the United States of America representing U.S. participants 
by state. The darker shaded colors indicate greater number of respondents.  
         1          6          40 
Number of respondents by state 
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Distribution of respondents  
Table 3.1 Demographic characteristics of survey respondents (N = 605). 
 
 
*Final survey responses were selected using a 2-tier validation process; 1) participants 
complete CSEs and 2) answered 85% or greater of the mandatory questions (i.e., not 
skip logic) and conduct clinical swallowing evaluations at their setting. 
 
 
 
Variable  (n) % 
Speech Pathologist   
 Yes 597 98.7 
 No 8 1.3 
Education   
 Masters 468 77.3 
 Doctorate 41 6.8 
 Student 82 13.6 
 No response 14 2.3 
Advanced Certification   
 Board registered swallowing 
specialist (BRS-S) 
18 2.9 
Experience in medical practice (years)   
 < 1  65 11.0 
 1 - 2  94 15.5 
 3 - 5  139 23.0 
 6 - 10  122 20.1 
 11 - 20  92 15.2 
 20 +  84 13.8 
 No response 9 1.48 
Country of Practice   
 USA 505 83.5 
 Canada 24 4.0 
 Other 76 12.5 
Work Environment**   
 Hospital  213 35.2 
 Skilled nursing facility 204 34.7 
 Outpatient rehabilitation 70 11.6 
 Multiple practice locations 49 8.1 
 Voice and swallow center 18 3.0 
 Private Practice 14 2.3 
 Home Health 14 2.3 
 Graduate training clinic 12 2.0 
 Other 11 1.8 
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Inclusion of Voluntary Cough Assessment 
Eighty-seven percent (529 of 605) of respondents reported they do assess voluntary cough 
during a CSE. Two participants (< 0.5%) did not respond, however they did note specific qualities 
that they look for in cough in response to a later question. See Table 3.2 for full detail of voluntary 
cough assessment by workplace, years of experience, and certification status. 
Table 3.2 Use of voluntary cough assessment by years of experience, practice setting, and 
level of certification (n = 603). 
 
* Of the 605 participants who responded to years of experience, 2 did not rate whether or not 
they assess voluntary cough. Description of working environment as follows: Hospital 
Variable 
Voluntary cough 
Assessment (n) 
Yes No 
Experience (Years)   
 < 1 52 13 
 1 - 2 81 13 
 3 - 5 125 13 
 6 - 10 106 16 
 11 - 20 80 11 
 20 + 76 8 
 No response 9 - 
 
Total 529 74 
Practice Setting   
 Home Health  12 2 
 Hospital 183 29 
 Multiple Locations 46 3 
 Other 8 3 
 Outpatient     
 Rehabilitation 
62 8 
 Private Practice 13 1 
 Skilled Nursing 178 25 
 Graduate Clinic 10 2 
 Voice/Swallow Center 17 1 
 No Response  - 
Total 529 74 
Certification Group   
 Student/Training 67 15 
 Masters 411 55 
 Advanced Training  37 4 
 No Response  14 - 
Total 529 74 
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includes individuals identified as working in a hospital setting including inpatient 
rehabilitation, multiple practice locations include individuals who identified working in 
multiple settings (i.e., hospital and skilled nursing facility). “Other” category included varied 
community based facilities for adults or medically fragile children. 
 
Interaction between clinical experience and certification level 
No significant difference was found between the years of clinical experience (ordinal rank 
groups) and use of voluntary cough (X2 (2) = 5.893, p = 0.43). Level of certification was 
categorized into three groups: 1) training status including SLP-assistant; student clinician 
(currently in a master’s program); or clinical fellow (has obtained a master’s degree but has not 
received professional certification), 2) professional level (CCC-SLP) and 3) advanced training 
(BRS-S or Ph.D.). There was no significant difference between certification level and use of 
voluntary cough (X2 (5) = 2.99, p = 0.22). Figure 3.2 depicts ranked frequencies for years of 
experience.  
 
Figure 3.2 Bar graph representing distribution of respondents who reported assessing 
voluntary cough during the clinical swallow grouped by years of experience. 
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Abnormal voluntary cough  
For the open format question, “What aspects of voluntary cough do you listen for to 
indicate abnormality (e.g., strength)?” 523 responses were analyzed (523/605) responded to this 
question). The number of descriptive terminologies used to describe disordered cough varied 
greatly. The minimum number of descriptors = 1, maximum = 7, the average number of descriptor 
to describe disordered cough was 2.7 ± 1.2. Trends in the use of the terms strength, loudness, 
effectiveness, and productive to describe aberrant voluntary cough sounds were analyzed. The 
most prevalent individual term was “strength.” This term was used by 458/523 respondents 
(87.5%) to evaluate voluntary cough for the purpose of assessing airway protection. When 
combing this term with “weak,” the number increased to 470/523 (89.9%) respondents. The second 
most commonly used term was “productive” with 91/523 (17.4%) respondents using this to assess 
ability to protect the airway. The third most commonly used term was “volume/loudness,” used by 
34/523 (6.5%) and respondents. The fourth most commonly used term was “effective/ineffective,” 
used by 19/523 (3.6%) respondents. Respondents also listed a variety of terms outside of the 
aforementioned categories including: “acoustics,” “respiratory strength,” “pharyngeal residue,” 
and “strength of exhalation.”  
Clinical Swallowing Assessment Pattern 
Participants reported having knowledge of one or all of the following clinical swallow 
protocols: Gugging Swallowing Screen (Trapl, Enderle, Nowotny, Teuschl, Matz, Dachenhausen, 
& Brainin, 2007); Modified Mann Assessment of Swallowing Ability (MASA) (Mann, 2002); The 
Toronto Bedside Swallowing Screening Test (TOR-BSST) (Martino, Silver, Teasell, Bayley, 
Nicholson, Streiner, & Diamant, 2009); and Yale 3 ounce water swallow test (Suiter, Sloggy, & 
Leder, 2014). Fifty-three percent of individuals use one of the validated clinical swallowing 
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protocols listed above. The option for open typed responses was provided in order facilitate insight 
as to why a validated protocol was not followed during a clinical swallowing evaluation. 
Responses were grouped thematically. The following reasons were provided for not following a 
validated CSE protocol: 1) “not part of policy at the hospital”; 2) “not a common practice in the 
particular country”; 3) “lack of training/education/access/familiarity”; 4) “learned a specific way 
of informal swallow clinical protocol”; 5) “a specific non-standardized protocol is the standard 
practice at the place of employment”; 6) “the evidence based practice for the protocol is not 
proven”; and/or 7) “the assessments are not personalized”. 
The most common assessment components that were reportedly used during a CSE 
included: 1) cranial nerve assessments; 2) oral feeding trials; 3) medical chart review; and 4) 
cognition/orientation testing. 
Discussion 
This is the first study to demonstrate that a majority of clinicians are using voluntary cough 
assessment during their CSE examinations, regardless of the clinician’s level of experience or 
relevant certification. While one may view this as positive trend in the SLP field; discouragingly, 
a large percentage of clinicians are still not using standardized/validated CSE protocols which use 
similar terminology such as “weak and strong” to denote cough impairment. Given, this lack of 
standardization, there also remains a discrepancy in the language/terminology used by clinicians 
to perceptually describe aberrant cough. 
According to survey responders, terms related to cough “strength” are most commonly 
used to define abnormality. However, rating a parameter such as strength with a binary outcome 
(weak or strong) has been found to show poor ability to detect abnormality. Smith-Hammond and 
colleagues (2001) demonstrated that CSE examinations of cough using terms of strength and 
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quality had very low sensitivity (42 and 26 respectively). The authors further noted that almost 
40% of patients who might have benefited from swallow therapy would not have been identified 
based on these cough metrics. Lack of agreement on descriptive terms of cough within speech 
language pathology practice and related fields studying cough may contribute to these findings as 
there is a lack of consistency and understanding of perceptual cough metrics to apply to our clinical 
populations. Objective cough rating using a scale indices or physiologic measurement of cough 
may provide a platform for a more cohesive and systematic measurement of cough impairment in 
the clinical setting.  
 Our data demonstrate that that the majority of survey participants (87%) are attending to the 
cough process as they indicated that they do assess voluntary cough during a clinical swallowing 
evaluation. When examining literature from our rehabilitation colleagues in physical and 
occupational therapies, we see that “strength” can measurable within an interval rating scale (Price, 
2012). Physiologically, a person’s strength can be measured by force against and object. 
Objectively, strength also is a measurable phenomenon. Therefore, clinically, we may be using an 
incorrect method of measurement by categorically defining perceptual cough features into “weak” 
or “strong”.  
 A promising alternative may be the use of a peak cough flow meter to evaluate cough. For 
example, Silverman et al., (2014) investigated cough measurement devices in healthy controls and 
persons with PD. Thirty-five healthy controls and thirty-five participants with PD were recruited; 
all participants were instructed to cough into three types of cough measurement devises: 1) an 
analog peak flow meter; 2) digital peak flow meter; and 3) a pneumotacograph (gold standard 
cough measurement). The participants were asked to produce three types of cough including a 
“weak, moderate, and strong” cough. Authors reported that average peak cough flow outcomes 
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were significantly different for both analog and digital peak flow meters and the pneumotacograph 
for the presence of disease (PD) and between genders; in addition, all of the devices produced 
similar normative outcome values (Silverman et al., 2014). Conversely, a study investigating the 
accuracy of portable devices measuring peak cough flow indicated poor agreement between gold 
standard pneumotactograph recordings and portable peak cough flow meters (Kulnik, MacBean, 
Birring, Moxham, Rafferty, Kalra, 2015).  Those authors highlighted the potential for inaccuracy 
when using this methodology to assess peak cough flow as authors reported poor agreement 
between the gold standard of airflow measurement and portable cough airflow devises (Kulnik, 
S.T., MacBean, V., Birring, S.S., Moxham, J., Rafferty, G.F, Kalra, L, 2015). As within clinical 
voice practice, clinicians are listening to voluntary cough and perceptually evaluating its 
characteristics. Given the current discrepancy in the use of objective means of cough assessment 
such as the peak flow meter and in the use of perceptual evaluation of cough, there is a need to 
investigate these properties in both healthy controls and a variety of patient populations.  
In many fields, agreement on, and consistent use of terminology is lacking and often there 
are overlapping and poorly defined terms to describe abnormality. Within the field of speech-
language pathology, we can look within the voice literature and see that many terms have been 
used to describe voice quality based on an auditory-perceptual assessment of voice (Hirano, 1981). 
Even among expert listeners, there can be discrepancies in reliability of voice ratings (Kreiman, 
1996). Though it should be noted that inter- and intra-rater reliability can be very high if the 
measurement methods are suitable for perceptual measurements (Shrivastav et al., 2005; Patel et 
al., 2010). Reliability is especially an issue for rating scale methods, which in clinical evaluations, 
typically involves a single judge and single trial listening.   
The auditory-perceptual evaluation most common in current clinical practice is the 
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Consensus Auditory-Perceptual Evaluation of Voice (CAPE-V) (Kempster, 2009) that relies on a 
series of rating scales and other perceptual judgments. This method is similar to the grade, 
roughness, breathiness, asthenia, and strain (GRABAS) scale described by (Hirano, 1981).  Under 
controlled laboratory conditions with expert judges, the inter- and intra-rater reliability of such 
measures can be quite high (Nemr, Simoes-Zenari, Cordeiro, Tsuji, Ogawa, Ubrig, & Menezes, 
2012) though other investigations have not shown such high reliability within a clinical setting 
(Kreiman, 1993). The voice quality literature has created a path to assess vocal quality using 
subjective perceptual rating scales as well as objective acoustic measures to inform the listener of 
abnormality, even though the most widely used measures (e.g., CAPE-V) are still considered 
inadequate by many professionals. Klein and colleagues (2000) examined the relationship between 
objective and subjective measures of voice quality and this contribution in the description of voice 
using a multichannel input for simultaneous assessment of acoustic and physiologic parameters. 
The authors concluded that the subjective voice ratings indeed provided useful information 
regarding the voice that the objective data alone did not convey. In the case of cough, we need to 
pick terminology, clearly define this terminology, and understand what it means physiologically.  
Limitations and Future Directions 
There are several limitations of this study associated with the phrasing of specific questions 
and those limitations make interpretation of some of the results less clear than originally planned.  
For example, in the question “What aspects of cough do you listen to when assessing voluntary 
cough?” the term “strength” was listed as an example of a voluntary cough feature. This potentially 
biased the responders to include strength or terms related to strength in their responses and may 
have led to over estimation of the use of such terms relative to terms that were not provided as 
examples.  Similarly, in the question “Do you assess voluntary cough (e.g., ask the patient to 
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perform a cough)?” the inclusion of the example in the parenthetical clause may have biased 
participants to include responses such as “perform a cough” leading to overestimation of such 
responses relative to other objectives measures such as objective peak cough flow meters to test 
voluntary cough function or nebulizers to assess reflexive cough function. Future work focusing 
on survey analysis of the variety of clinical cough testing methodologies that are currently being 
used and also clinicians feeling towards to use of new cough testing methodologies may help shape 
future research aims.  
Conclusion 
The aim of the investigation was to define current practices for subjective voluntary cough 
assessment during the CSE. It was hypothesized that across a variety of medical settings, that 
subjective assessment of voluntary cough sound is not routinely implemented despite years of 
training or clinical experience. The results of this study did not support that hypothesis as 89% of 
survey respondents replied that they do assess voluntary cough (e.g. ask the patient to perform a 
cough) during the CSE, and the use of voluntary cough testing did not differ between years of 
clinical experience or certification type (i.e., advanced clinical training).  
Cough evaluation within the clinical setting is gaining attention. Researchers are reporting 
the utility of hand held meters to evaluate cough function in select patient populations (Silverman 
et al., 2014), there are reports of perceptual variants of cough and how this relates to airflow 
measures (Laciuga et al., 2016), and several authors have published data on the use of cough 
airflow flow testing using a pneumotacograph to determine airway safety status. The current 
survey completed by 605 participants’ shows that a majority of survey respondents across practice 
settings, levels of experience, and certification are clinically assessing voluntary cough function 
as part of their practice. With a growing body of basic and clinical literature demonstrating 
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relationships between swallowing the airway protective behavior of cough, there is an urgent need 
for standardization of cough assessment protocols and understanding terminology used to describe 
aberrant cough.  
Expert clinicians and scientists agree that cough is a behavior that is essential to one’s 
health and wellbeing especially those who are at risk for penetration or aspiration events. 
Standardization of cough assessment and common language used to describe aberrant cough may 
help improve dystussia evaluation as well as direct future research aims. 
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CHAPTER FOUR  
 
PERCEPTUAL AND CLINICAL INDICES OF COUGH ASSESSMENT 
Introduction  
Voluntary cough measures are predictive of airway safety status during swallowing in 
several patient populations including stroke (Smith Hammond C.A. , 2001; Smith Hammond, 
Goldstein, Horner, Ying, Gray, Gonzalez-Rothi, & Bolser, 2009), Parkinson’s disease (PD) (Pitts, 
Bolser, Rosenbek, Troche, & Sapienza, 2008; Pitts, Troche, Mann, Rosenbek, Okun, & Sapienza, 
2010) and Amyotrophic Lateral Sclerosis (ALS) (Plowman, Watts, Robison, Tabor, Dion, 
Gaziano, Vu, & Gooch, 2016). Voluntary cough testing methodology has varied across these 
studies; however, all have utilized cough airflow testing (the current gold-standard cough 
evaluation method). This methodology requires costly equipment and the analysis is labor 
intensive, time consuming, and requires intensive training to perform expert evaluation of the 
cough airflow waveforms. The modified barium swallow study (MBS) (the current gold-standard 
swallowing evaluation method) affords visualization of airway protection safety status in real time 
(Logemann, 1984). The Penetration Aspiration Scale (PAS) (Rosenbek, Robbins, Roecker, Coyle, 
& Wood, 1996) is an 8-point rating scale used to quantify and categorize level of airway protection 
based off of results from the MBS. A rating of 1 indicates that nothing has entered the laryngeal 
vestibule and a rating of 8 indicates that swallowed material has gone below the level of the true 
vocal folds and a cough response was not elicited. The PAS scale does contain information 
regarding a patient’s ability to protect the airway during a swallowing task (i.e., the attempt to 
“eject” the material or cough was successful or not) and therefore is efficient in understanding if a 
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cough is effective or not. Unfortunately, the MBS may be costly and not readily available to all 
clinicians such as those in skilled nursing facilities, home-health practitioners, or those who 
provide clinical assessment via teleheath. Many clinicians utilize swallowing screening and 
clinical swallowing evaluations to determine both airway safety status and assess a patient’s ability 
to effectively protect the airway. 
Although there are data to support the relationship between cough and swallowing, not all 
available clinical swallowing assessment protocols contain a cough-testing component (Watts, 
Tabor, & Plowman, 2016). Cough effectiveness is a term used to describe cough in terms of the 
ability of the force of that cough to expel material from the airway. Current clinical evaluation of 
cough is focused on cough frequency, peak expiratory airflow rate collected via a hand-held peak 
flow meter, and subjective ratings of cough “effectiveness” in a binary manner (i.e., weak or 
strong).  To this point, little is known regarding the reliability or validity of clinician perceptions 
of voluntary cough effectiveness during the clinical swallow evaluation (Laciuga, Brandimore, 
Troche, & Hegland, 2016).  
There is a paucity of data on the ways in which audible perceptual features of dystussia 
(disordered cough) may differ from audible features of normal cough. Additionally, there is limited 
knowledge on whether perceptual parameters of cough can inform clinicians of decreased airway 
protection during swallowing, or if perceptual measures of cough are a reliable means to judge 
such differences in disordered vs. functional cough. There is currently no standardized tool to 
assess subjective ratings of cough impairment by healthcare professionals. There remains a great 
clinical need for a cost-effective, readily available, low-tech, sensitive and specific clinical tools 
to evaluate voluntary cough function. A visual analog scale (VAS) is often used to characterize 
the intensity of a biological function across a simple numeric continuum (Gould et al., 2001). 
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However, there is some debate throughout the literature as to whether the use of a VAS is credible 
measure of certain functions (Price, Staud, & Robinson, 2012). The VAS, in the context of 
quantifying the perception of pain, has been reported to demonstrate ratio-scale properties and be 
sensitive to small changes in the perception of pain (Myles & Urquhart, 2005; Price, McGrath, 
Rafii, & Buckingham, 1983; Price, Bush, Long, Harkins, 1994; Price & Harkins, 1987). The goals 
of this study were to determine if there were differences between airway safety groups in 
individuals with ALS for in perceptual measures of cough strength, loudness, and effectiveness as 
measured by a VAS, and for the presence/absence of aberrant cough features. We hypothesized 
that measures of cough strength, loudness, and effectiveness would be reduced in individuals with 
unsafe swallowing relative to those with safe swallowing. Further, we hypothesized that 
individuals with unsafe swallowing would demonstrate one or more identifiable aberrant cough 
features. 
Methods  
Participants 
Retrospective data were collected from participants who were previously enrolled in a pilot 
study and a grant-funded (R21) research study run by principle investigator Dr. Emily K. 
Plowman. Patients were enrolled in a treatment study assessing the effects of expiratory muscle 
strength training (EMST) on swallow and respiratory function in individuals with ALS. Study data 
was collected from baseline study assessment prior to participation in respiratory training. 
Participants included 44 individuals with a diagnosis of probable/definite Amyotrophic Lateral 
Sclerosis (ALS) in accordance with the Revised El-Escorial Criteria (Brooks Br, 2000). According 
to the study protocol designed by Dr. Plowman, all patients were screened with specific inclusion 
and exclusion criteria including: 1) diagnosis of probable or definite ALS; 2) Amyotrophic Lateral 
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Sclerosis Rating Scale Revised score (ALSFRS-R) (Cedarbaum, 1999) greater than 32; 3) reduced 
maximum expiratory pressure compared to published normative data for gender and age (Wilson, 
1984 ); 4) forced vital capacity greater than 65%; 5) cognition within normal limits as determined 
by > 24 points on the Mini Mental Status Exam (Folstein, 1975); 6) no reported allergies to barium; 
7) no current tracheotomy or mechanical ventilation; 8) absence of diaphragmatic pacer; and 9) no 
significant concurrent respiratory disease (e.g., COPD) (Plowman, Watts, Tabor, Robison, 
Gaziano, Domer, Richter, Vu T, Gooch C, 2016) 
Equipment 
Two testing procedures were included for analysis: 1) videofluoroscopic evaluation of 
swallowing and 2) standardized voluntary cough spirometry testing. For the videofluoroscopic 
swallow diagnostic study, a Phillips BV Endura fluoroscopic C-arm unit (GE OEC 8800 Digital 
Mobile C-Arm system type 718074) was used to acquire the radiographic images at 30 frames per 
second. Cough spirometry testing was recorded on each patient using the following methodology. 
An oral pneumotachograph (MLT 1000, ADInstruments, Inc; Colorado Springs, CO) was 
connected to a spirometer filter (MQ 304 Spirometer Filter, Vacumed; Ventura, CA) which 
recorded airflow measures via a transducer (Powerlab (8/35, ADInstruments, Inc Vacumed; 
Ventura, CA) during voluntary cough production. The pneumotachograph, fitted with a sanitary 
filter, was held in place by the examiner. 
Testing Protocols 
1) Swallow function: Patients were evaluated using a videofluoroscopic evaluation. 
Videofluoroscopy is considered the “gold standard” to assess airway compromise across multiple 
patient populations. Participants were seated in an upright position and both lateral and anterior 
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images were obtained during the consumption of the following barium contrast boluses via 
syringe: thin liquid contrast in volumes of, 1 cc, 5 cc, and 20 cc, and 5 cc of barium paste. The 20-
cc thin liquid trial was utilized for evaluation of airway compromise. If the patient was unable to 
swallow 20 cc of the liquid contrast, the largest bolus challenge that the patient completed was 
assessed. A blinded rater evaluated the level of airway compromise live and then a second blinded 
rater provided reliability using the recorded video. Airway compromise was assessed using the 
standardized PAS. The PAS is an 8-point scale that assesses penetration and aspiration where 1 
equals no penetration or aspiration and 8 equals aspiration without a cough response (i.e., silent 
aspiration). Using the PAS scale, participants where stratified into one of two swallowing safety 
groups. A PAS score of 1 or 2 was classified as “safe” swallowing and a PAS score of 3 
(penetration above the level of the folds with residue) to 8 was classified as “unsafe” swallowing.  
2) Cough function: Patients were seated upright in a chair or wheelchair with their feet on 
the floor and their arms placed on the armrests. A respiratory filter in line with a 
pneumotachograph was placed in the participant’s mouth. He or she was instructed to breathe 
normally for at least three tidal breaths to acclimate to the filter. According the protocol outlined 
in the EMST study designed by Dr. Plowman, they were then instructed to take a deep breath and, 
“cough hard like there is something stuck in your throat”. The patient completed this activity three 
times. Collection of this airflow data was also audio-recorded using a Sony HD HandyCam video 
recorder positioned directly in line with the pneumotachograph. This audio recording provided a 
means to re-assess subjective ratings of cough effectiveness, loudness, and volume after primary 
data collection.   
All data was video and audio recorded. Two raters assessed perceptual cough features using 
audiovisual recordings after the cough airflow data was collected. Raters evaluated perceived 
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cough strength, loudness, and effectiveness using a 100-mm, visual-analog scale (VAS) (see 
Figure 4.1). More specifically, the perceived quality (weak, moderate, and strong) for cough 
strength, loudness, and effectiveness were judged by marking a horizontal tic mark on a 100-mm 
vertical VAS. The total possible rating for each perceptual measure was out of a 100 with 0 being 
a poor rating, and 100 being a (perceptually) excellent rating. Scores for each measure were 
derived by using a ruler to measure distance (in millimeters) from the “0” end point on the line to 
where the horizontal tic marks were made. Additionally, raters determined the presence or absence 
of binary cough quality ratings (huffing, voicing, wet, inspiratory stridor) based on operational 
definitions (see Table 4.1).  
 Rater 1 reviewed all 44-recorded assessments and made judgments of cough strength, 
loudness, and effectiveness as well as determined the presence/absence of aberrant cough features. 
Using a random number generator, 20% of the 44 auditory cough epochs sampled (9) were 
randomly selected to be re-analyzed by a second blinded rater. Rater 2 utilized the recorded 
audio/video files to assess all perceptual parameters at a time point after data collection.  
 
 
 
 
 
 
 
Table 4.1 Definitions of aberrant cough signs; perceptually judged to be 
present/absent by a blinded rater. 
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Figure 4.1 Three vertically positioned 100-mm lines were used as a VAS for perceptual ratings 
of cough strength, loudness, and effectiveness. Next to the lines were references for each 
perceptual VAS measure. As such, for the perceptual measure of cough strength, a horizontal 
tic mark made along the lower end of the line indicated a “weak” cough, a horizontal tic mark 
within the mid-range of the line indicated a “moderately strong” cough and a horizontal tic along 
the top of the vertical indicated a very strong cough. Precise numerical measurements were 
derived by using a ruler to measure the distance from bottom of the vertical line (0) to the 
horizontal tic mark provided by the rater. Each perceptual measure was out of a total score of 
100. 
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Data Analysis and Statistics 
 Because of uncertainty about whether the measurement properties of the VAS scale should 
be as ordinal or interval data, and uncertainty about the underlying distributions (i.e., normal or 
not) of scores given the limited size of the data set, non-parametric Mann Whitney U tests as well 
as T tests were used to evaluate the hypotheses that safe and unsafe swallowing groups were 
associated with statistically significant different perceptual VAS scores. These tests were 
performed for the individual VAS ratings of  
Results  
A total of 44 individuals (30 male, 14 female) were included in the analysis. See Table 4.2 
for description of participants. A blinded rater reviewed the modified barium swallow studies and 
identified 26 safe swallowers (PAS < 2) and 18 unsafe swallowers (PAS > 3) within the ALS 
participant sample.  
 
 
Quality Parameter: Operational Definition: 
Huffing: Blowing or puffing with force during 
the cough attempt.  
 
Voicing: Vocalization during the cough attempt. 
 
Wet / Gurgled: Cough sounds broken, irregular, or 
noisy. 
 
Inspiratory Stridor: Harsh, grading, or creaking sound 
while breath is taken in during first 
phase of voluntary cough.  
 
 
 81 
 
 
Table 4.2 Participant demographics (N = 44). Sample included 26 participants with unsafe 
swallowing as defined by a PAS score < 2, and 18 unsafe swallowers as defined by a PAS score 
of > 3. 
 
 
*Disease duration as measured from time of symptom onset to clinical study assessment. 
Visual Analog Scale  
 
Using a non-parametric statistical approach, a significant group difference was revealed 
between mean VAS scores in safe (50.88/100) vs. unsafe (33.56/100) swallow groups for the 
perceptual measure of cough effectiveness (U = 148, p = 0.04) while the group difference was just 
above our 0.05 significance criteria for the perceptual measure of cough strength (U = 152.5, p = 
0.052). Using a parametric approach, a significant difference was revealed between mean VAS 
scores in the safe (43.3/100) vs. unsafe (28/100) swallow groups for the perceptual measure of 
cough strength (t (42) = 2.08, p < 0.05; (Figure 4.2) and for cough effectiveness (t (42) = 2.10, p 
< 0.005). 
 
 
Variable Overall 
Safe  
Swallowers 
Unsafe 
Swallowers 
 Mean (SD) Range Mean (SD) Range Mean (SD) 
 
Range 
 
Age (years) 
 
62  (+/- 10.3) 30 - 83 59 (+/- 11) 30 - 75 66 (+/- 7.6) 57 - 83 
ALSFRS-R 
 
33 (+/- 7.9) 16 - 47 34 (+/- 7.4) 16 - 47 30 (+/- 8.3) 16 - 47 
Disease Duration 
(months)* 
21 (+/- 13.8) 
1 - 61 
 
21 (+/- 13.4) 8 - 54 21 (+/- 14.8) 1 - 61 
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Figure 4.2 A bar graph indicating difference in mean perceptual VAS scores of voluntary 
cough strength between safe (PAS < 2) vs. unsafe (PAS > 2) swallow groups t(42)=2.08, p < 
0.05. 
 
Moderate positive correlations were revealed between perceptual VAS indices and global 
disease rating scores. Low perceptual VAS clinical ratings of cough “strength” were associated 
with global disease progression (rho = 0.67, p = 0.001). Likewise, low perceptual ratings of cough 
“loudness” were associated with global disease progression (rho = 0.68, p = 0.000). Similarly, low 
perceptual ratings of cough “effectiveness” were associated with global disease progression (rho 
= 0.64, p = 0.000). Additionally, perceptual measures of cough strength and effectiveness with 
strongly positively correlated (rho = 0.94, p = 0.00) See Figure 4.3 for scatterplots representing 
these correlations.  
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Figure 4.3 Scatterplots demonstrating: A) a moderate positive correlation between disease 
rating scale score, (the ALS functional rating scale ALSFRS-R) and perceptual VAS ratings of 
cough strength; B) a moderate positive correlation between the ALSFRS-R score and loudness 
score; C) a moderate positive correlation between the ALSFRS-R score and cough effectiveness 
score; and D) a strong correlation between the perceptual rating scores for cough strength and 
effectiveness.  
 
Presence/absence of Aberrant Cough Sounds 
Voicing was identified as the most aberrant cough sound feature overall as determined by 
a frequency count of cough sounds. Huffing was present in a greater number of ALS individuals 
who penetrated/aspirated (38.88%) vs. those who did not (3.84%), (χ2 (1) = 8.78, p = 0.003). The 
presence of huffing was also associated with swallowing safety status and 10 times more prevalent 
in ALS patients with unsafe swallowing (see Table 4.3). 
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Table 4.3 Distribution for the presence/absence of perceptual cough features including voicing, 
huffing, inspiratory stridor, and wet/gurgled quality. The distribution is represented for the over 
group (all 44 participants) and by airway safety group.  The presence of “huffing” was revealed 
as statistically significant and found in a higher portion on unsafe vs. safe swallowers. Table 4.3 
also displays the inter-rater Kappa values as determined between rater 1 and rater 2. 
 
 
 
*Participant counted two times in tally for displaying more than one aberrant feature. 
 
Reliability of the VAS for Cough Assessment 
Good inter-rater reliability (between rater 1 and rater 2) was revealed for all VAS measures. 
ICC values for strength were 0.79 (CI = 95%, 0.615 – 0.885, p = 0.000), ICC values for volume 
were 0.79 (CI = 95%, 0.627 – 0.889, p = 0.000), and ICC values for effectiveness were 0.77 (CI 
= 95%, 0.592 – 0.879, p = 0.000). Excellent intra-rater reliability was shown for all VAS measures 
as assessed by rater 1 at two different time periods (though note that this is based only on 8 sample 
points). ICC value for strength was 0.899, volume was 0.945, and effectiveness was 0.906. 
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Reliability Binary outcomes 
Weak and minimal inter-rater reliability was shown between rater 1 and rater 2 for the 
identification (presence or absence) of binary cough quality ratings of huffing, voicing, and 
inspiratory stridor, moderate reliability was shown for the detection of the sound wet/gurgles (see 
table 4.3). Fair intra-reliability was found between rater 1 assessments of binary measures.  
Discussion 
This study represents the first attempt to investigate perceptual ratings of cough using a 
visual analog scale (VAS) and defined binary ratings of aberrant cough for the assessment of 
dysphagia in ALS. Conservatively, the VAS outcome measures were considered ordinal data and 
non-parametric statistics were used to assess differences in mean scores between airway safety 
groups. There were significant differences in the perceptual measures of cough “effectiveness” 
between airway safety groups and this rating was also found to have good inter reliability (between 
rater 1 and rater 2 when assessed at different time points).  
Visual analog scales are quick methods of obtaining quantifiable information. The 
continuous 100 mm line version of the VAS has shown improved sensitivity for measurement of 
subjective assessments of pain and mood (Pfennings, Cohen, & Van der Ploeg, 1995). Anchors on 
the scale are may represent a point of reference for the rater using the scale and may indicate 
opposite descriptors such as “cold and hot”. There are ways to consider improvement of the VAS 
scale rating system to evaluate perceptual indices of cough used within this study. The anchor 
reference for cough measurement could be changed by using anchors that represent a more 
universal point of reference for raters such as color (i.e., bright blue and pale blue). Changing the 
reference points to a relatable reference other than extremes of cough may provide more accurate 
measurement of what the perceived cough “strength” is.  
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Although the use of VAS scores for the subjective assessment of cough impairment may 
only represent incremental improvements in clinical cough measurement and there is debate on 
the use of such rating scales in perceptual rating, there remains a dire need to move beyond binary 
ratings of clinical cough assessment. As demonstrated in our data, the presence of “huffing” was 
present in more patients with unsafe swallowing than safe swallowing, however, this measure was 
not shown to be reliable between raters. Clinically, the use of more objective cough measurements 
have the potential to: 1) more accurately identify patients with cough impairments who are at high 
risk for aspiration; 2) provide a quantifiable, objective measure of cough impairment to identify 
pre/post intervention change; and 3) provide a universal system of cough measurement that is 
easily accessible to and understood by clinicians.  
Limitations and Future Direction 
In this investigation, the perceptual judgments of cough strength, loudness, and 
effectiveness were assessed via recordings of the cough process. Placement of the recording 
devices was not standardized for optimal audiovisual data collection and subsequent analyses. 
Future work should include standardization of cough recording during the data collection process; 
in addition, both online (during the collection of cough data) and recorded cough sounds should 
be assessed. Further work is needed to understand VAS measurements of cough in several patient 
populations and to study this measurement in a more controlled manner to limit contextual biases. 
Additionally, there remains a need for objective quantification of cough sound patterns to improve 
the assessment of patients who are at risk for having undetected dysphagia and/or dystussia. 
Conclusions  
 The goals of this study were to determine if individuals with ALS who were classified by 
airway safety groups (safe vs. unsafe swallowing) differed in terms of perceptual measures of 
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cough strength, loudness, and effectiveness or in the presence/absence of aberrant cough features. 
We hypothesized that measures of cough strength, loudness, and effectiveness would be reduced 
in individuals with unsafe swallowing relative to individuals with safe swallowing. Further, we 
hypothesized that individuals with unsafe swallowing would demonstrate one or more aberrant 
cough features. The results of the study partially supported the hypothesis.  Visual analog scale 
measurement of cough “effectiveness” was significantly lower in the unsafe swallowing group and 
the measurement of “strength” reached near significance and was lower in the unsafe swallowing 
group. Additionally, the aberrant cough feature of “huffing” was associated with the unsafe 
swallowing group.  
 This study attempted to identify the perceptual differences within cough features in a way 
that could be easily conducted in a clinical setting and quickly interpreted. Although differences 
were found for perceptual ratings, the judgments were made retrospectively and further work is 
warranted to determine feasibility of use in a clinical setting.  
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CHAPTER FIVE  
 
PHYSIOLOGIC ASSESSMENT OF VOLUNTARY COUGH IN ALS 
Introduction 
Amyotrophic Lateral Sclerosis (ALS) is a progressive and debilitating neurodegenerative 
disease resulting in diffuse and progressive muscle wasting and death (Wijesekera, 2009). 
Dysphagia, or swallowing impairment, is prevalent in this patient population (Ertekin, 2000). 
Presenting symptoms and disease onset are heterogeneous; thus, dysphagia symptoms manifest 
differently across patients and can be difficult to assess clinically. Individuals with ALS may 
present with bulbar onset of the disease in which case lingual and masticatory deficits are 
prominent features of dysphagia. In the spinal onset variant of ALS, limb motor impairment is the 
first salient feature identified (Ruoppolo, 2013). Recent evidence indicates that, although patients 
with bulbar onset have more prevalent oromotor features; in patients with spinal onset dysarthria 
is significantly correlated with presence of dysphagia (Da Costa Franceschini, 2015). 
In addition to sensorimotor dysfunction of the swallowing mechanism, ALS 
simultaneously results in motor cough deficits, (Plowman et al., 2016) and presumably sensory 
cough deficits. Thus, despite onset type, patients are likely to develop pervasive airway protective 
dysfunction characterized by both dysphagia and impaired reflexive cough (Ruoppolo, 2013). 
There are relationships between cough and swallow at a neural (Gestreau, Grelot, & Bianchi, 2000; 
Gestreau, 1996; Oku, Tanaka, & Ezure, 1994) and anatomical/functional level (Pitts, Bolser, 
Rosenbek, Troche, & Sapienza, 2008; Plowman, Watts, Robison, Tabor, Dion, Gaziano, Vu, & 
Gooch, 2016; Smith Hammond, 2001). Recent work by Plowman and colleagues (2016) has shown 
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that impaired voluntary cough function identifies patients with ALS who are at risk for 
penetration/aspiration. The authors postulated that there might be clinical utility for the use of 
voluntary cough testing to detect presence of dysphagia in this patient population. Although cough 
may be a clinically useful tool to determine compromised swallowing function or the ability to 
clear aspirant material, cough evaluation methodology and implementation is widely varied 
throughout the literature (Watts, Tabor, & Plowman, 2016).  
Methodology for common clinical cough testing includes subjective assessments of 
strength and/or weakness (as presented in Chapter 3). This is regardless of clinician demographics 
such as years of experience, certification status, and/or practice setting. Unfortunately, it has been 
shown that subjective assessments of cough are unreliable and are not able to detect swallowing 
impairment. For example, McCullough et al. (2005) reported high sensitivities (<79%) but low 
specificities (<42%) for detection of aspiration using perceptual ratings. The authors reported that 
almost half of the at-risk patients were wrongly categorized based on a “weak” cough rating.  
Acoustic measurements of voluntary cough sounds have been investigated in healthy 
adults. Olia et al. (2000) studied 234 cough patterns in healthy male and female adults. The authors 
subdivided cough patterns into distinct anthropomorphic features consisting of three components 
1) explosive phase (phase timing and amplitude, 2) continuous phase (phase timing), and 3) the 
variable phase (timing). Authors reported that there were significant differences found between 
gender for the length of the expulsive phase, frequency of the first phase, and highest continuous 
frequency of the continuous phase. Although there are limitations in acoustic cough analysis, these 
studies are necessary to provide objective qualification of a subjective physiologic event. Objective 
quantification of cough may help to determine change in airway protection in specific diseases 
over time or monitor improvement in airway protection following therapeutic intervention 
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(Korpas, 1996).  
Therefore, the aim of this study was to determine anthropomorphic characteristics of 
voluntary cough acoustic signals in individuals with ALS and healthy controls. Given differences 
in anthropomorphic features of cough previously found in participants with and without lung 
disease, it is hypothesized that there will be anthropomorphic differences between healthy controls 
and patients with ALS and between patients with ALS who are safe swallowers and those who are 
not safe swallowers.  
Methods 
Participants 
Participants included 10 patients diagnosed with ALS according the El Escorial Criteria 
(Brooks et al., 2000); 5 males and 5 females with bulbar, spinal, and mixed disease onsets, and 10 
healthy aged-matched controls; 5 males and 5 females with no known history of pulmonary 
disease. ALS patients were recruited from the Morsani Medical Center’s ALS neurology clinic, 
and the Center for Swallowing Disorders. This study received approval by the University of South 
Florida Institutional Review Board (#00023151) (see Appendix D) In addition to the diagnoses 
above, specific inclusion criteria included: 1) cognition within normal limits as determined by > 
24 points on the Mini Mental Status Exam (Reisberg, 1982). Specific exclusion criteria include: 
1) presence of tracheotomy or mechanical ventilation; 2) presence of diaphragmatic pacer; 3) 
diagnosis of significant concurrent respiratory disease (e.g. COPD); or 4) allergies to barium.  
Testing Protocol  
Once enrolled, participants were assigned a study number and underwent all testing 
procedures on the same day. Data collection was counterbalanced in order to account for fatigue 
in this patient population. Assessments included: 1) swallowing evaluation using 
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videofluoroscopy; 2) physiologic cough spirometry testing coupled with acoustic recording; 3) 
voluntary peak expiratory flow rate cough testing; 4) spirometry testing; and 5) completion of 
disease-specific rating scales including the ALS functional rating scale revised (ALSFRS-R) 
(Cedarbaum, et al., 1999). 
Swallowing  
Swallowing was assessed using the modified barium swallow study (MBSS). The MBSS 
is the gold standard evaluation for swallowing function. Participants were seated in an upright 
position. A Phillips BV Endura fluoroscopic C-arm unit (GE OEC 8800 Digital Mobile C-Arm 
system type 718074) was used to collect radiographic images of the swallow (30 frames/second); 
images were collected in both a lateral and anterior-posterior viewing plane. A Kay Pentax 
Swallowing Signals Lab unit (Kay Pentax, Lincoln Park, NJ) digitally recorded the fluoroscopic 
images that were stored for subsequent analysis. The standardized protocol consistent of the 
following bolus challenges: 1) 1-cc, 5-cc, 10-cc and cup sips of ultra-thin liquid contrast, 2) 5-cc 
of barium paste, and 3) ¼ of graham cracker coated with 5 cc barium paste in the lateral view; and 
4) cup sips of ultra-thin barium liquid, 5) ¼ of graham cracker coated with 5 cc barium paste, and 
6) 13-mm barium tablet in the anterior/posterior view. To ensure patient safety, the sequence of 
bolus presentations may have been altered. The MBS study was discontinued if the patient silently 
aspirated and could not tolerate further swallow testing procedures.  
Acquisition of Cough Airflow and Acoustic Waveforms 
Cough airflow during voluntary cough was assessed for each patient using spirometry. 
Patients were asked to “cough as if something were stuck in your throat.” Prior to airflow data 
collection, the airflow signal was calibrated using a 3-liter syringe. The patient was placed in a 
seated position; a spirometer filter (MQ 304 Spirometer Filter, Vacumed; Ventura, CA) was 
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coupled to an oral pneumotachograph (MLT 1000, ADInstruments, Inc; Colorado Springs, CO). 
The airflow signal was measured via a spirometer (ADInstruments, Inc, Colorado Springs, CO), 
which was attached to data acquisition hardware (PowerLab System 16/35, ADInstruments, Inc).  
Acoustic cough recordings were collected in conjunction with airflow measures and 
independent of airflow measures (Figure 5.1). An Audio-technica microphone (ATM73a) with the 
mouthpiece placed at a standardized distance from the patient’s oral cavity. Prior to collection of 
acoustic cough data, the acoustic signal was calibrated using a 90 dB pure tone. The microphone 
was routed to a preamplifier unit and the signal split into two A/D channels. Via software control, 
the sensitivity of each channel was set to allow simultaneous low and high-sensitivity recordings. 
This allowed for very high cough sound pressure levels to be recorded without clipping on the 
low-sensitivity channel and very low sound pressure levels to be recorded with an adequate signal-
to-noise ratio. Audiovisual recording of the cough assessment was obtained using a Sony HD 
HandyCam video recorder positioned directly in line with the patient at a three-foot distance.  
Data Analysis and Statistics 
Cough Airflow 
Offline analysis of the airflow and acoustic waveforms were completed using separate 
software utilities consisting of a series of MATLAB scripts. Each of the MATLAB utilities 
included several automatic assessment features to reduce measurement error (Appendix E). 
For the airflow waveform, physiologic aspects of the cough airflow signal were measured as in 
previous investigations of voluntary cough production, (Smith Hammond C.A., 2001). As 
previously described in publications of cough airflow analysis, the following measures of cough 
airflow were derived with MATLAB software scripts: 1) inspiratory phase duration: this is defined 
in the literature as the time from the start of the inspiratory event (airflow crossing 0 L/s) to the 
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beginning the compression phase of cough (airflow reaches 0 L/s and remains relatively stable); 
2) inspiratory peak flow: this is determined as the lowest peak measurement during the inspiration 
(-L/s); 3) compression phase duration: commonly defined within the literature as time total time 
of glottis closure measured from the end of the inspiration to the start of the expiratory phase; 4) 
expiratory rise time: this time measurement is referred to as the time it takes from the opening of 
the glottis to reach peak expiratory flow. It is measured from the start of the expiratory phase to 
the time the peak expiratory flow occurs; 5) expiratory peak airflow: this is referred to as the 
highest peak point during a cough expiration. It is measured by identifying the highest peak in an 
expiration (L/s); and 6) cough volume acceleration: this measurement is a calculation of expiratory 
peak flow/expiratory rise time often described within the literature as the effectiveness of the 
cough. These samples were analyzed separately from the acoustic analysis and were derived at 
separate intervals during the cough testing procedure. 
Cough Acoustics 
Analysis of acoustic cough waveforms were processed and measured using the LabChart 
(version 7) software and subsequently exported to MATLAB (Mathworks, Inc.). 
Anthropomorphic features of cough sound included the following measures: (see figure 5.2). 1) 
expulsive cough phase time: onset time of the cough signal to the time of the first peak frequency; 
2) continuous cough phase time: time from the first peak frequency to the time of the second peak 
frequency; 3) variable cough phase time: time of the second peak frequency to the end of the 
acoustic cough signal; 4) total length of acoustic cough signal: time from the onset of the acoustic 
cough signal to the end of the acoustic cough signal; and 5) augmenting and decrementing cough 
pattern: acoustic cough recording in microvolts (mV) was analyzed for the cough signal pattern 
(see Figure 5.3).  
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Figure 5.1 Image depicts a sample data collection page rendered using LabChart version7. Time 
is along the x-axis. There are 4 panels displayed along the y-axis. The first panel represents the 
raw cough waveform, second panel represents the filtered cough waveform, third panel is a high 
sensitivity data capture of acoustic recording and the fourth panel is a low sensitivity data capture 
of acoustic signal. Acoustic data were collected in two ways, simultaneously with airflow 
(pictured) and independently (not pictured) without airflow. Acoustic recordings without airflow 
were used for analysis.  
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Figure 5.2 Anthropomorphic features of acoustic cough signals were tagged and recorded. Time 
and peak amplitude were analyzed to derive final measures: A) onset time of the cough signal 
to the time of the first peak frequency B) time from the first peak frequency to the time of the 
second peak frequency, and C) time of the second peak frequency to the end of the acoustic 
cough signal. 
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Figure 5.3 Cough waveform variations were classified for single acoustic cough signals; they 
were analyzed from the same recording channel for each subject according to the following 
definitions: A) fast augmenting signal and fast decrementing signal; B) slow augmenting and 
slow decrementing signal; C) fast augmenting and slow decrementing signal; and D) slow 
augmenting and fast decrementing acoustic signal. 
 
Handheld Peak Flow Meter Testing 
Voluntary peak cough airflow was measured for each patient using a portable, hand-held 
flow meter. The patient remained in a seated position. A Mini Wright Peak Flow Meter (KW Med, 
Inc., Antioch, IL) was placed in the patient’s mouth. The clinician helped to create a tight lip seal 
around mouthpiece. If needed, the nose was occluded with nose clips for the cough task. The 
patient was asked to cough “as if something were stuck in their throat.” Standard-range (60 to 850 
liters per minute) and low-range (30 to 400 liters per minute) peak flow meters were available for 
testing depending on the patients’ typical airflow. Each patient performed three trials of the peak 
cough flow test; an average of the three trials was used for subsequent analysis. 
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Respiratory function  
Forced vital capacity (FVC) was assessed with a Micro 1 Handheld Spirometer 
(CareFusion, Vyaire Medical, Mettawa, IL). The patient was instructed to sit fully upright and 
performed a maximal inhalation and exhalation effort with cueing from the experimenter. 
Statistical Analysis 
Descriptive statistics including mean, standard deviation, and range were used to describe 
demographic characteristics of the sample. Given the largely heterogeneous presentation of the 
sample population, normal distribution was not assumed. Therefore, the non-parametric Mann 
Whitney U Test was used to compare sample means between cough airflow measures in safe (PAS 
< 2) and unsafe swallowing groups (PAS > 3); and anthropomorphic acoustic cough measures 
between healthy controls and patients with ALS and across airway safety groups in ALS.  
Spearman’s Rho Correlation analysis with alpha set at 0.05 was utilized be used to determine 
associations between continuous spirometry data and voluntary cough airflow and acoustic 
measures.  
Results 
Patient Demographics 
  Ten patients with ALS underwent evaluation. Mean age of the sample was 63 years (range 
39-73 years), and 50% of the sample was female. All subjects scored > 26 on the MMSE and were 
deemed appropriate to participate in the cough and swallow evaluation protocols. Table 5.1 
summarizes the demographic and disease data for each subject. Of the ten ALS patients evaluated, 
5 patients were judged to have unsafe swallowing (PAS score > 3) as evaluated during any swallow 
task completed during the swallow study protocol (see Table 5.1, second column). Peak cough 
flow testing and respiratory function information for each patient can be found in table 5.2. In 
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addition, 10 healthy control subjects underwent acoustic cough evaluation. Mean age of the control 
sample was 59.2 years (range 42 to 75 years), and 50% of the sample was female. 
Table 5.1 ALS participant demographics including global disease rating scale with subscale 
bulbar and respiratory domain data. *Disease duration is reported as time (in months) from 
reported symptom onset to study assessment date.  
 
Participant 
ID 
Gender 
PAS 
Score 
ALSFRS-R 
Score 
 
ALSFRS-R 
Bulbar 
 
 
ALSFRS-R 
Respiratory 
 
Disease 
Onset 
Disease 
Duration 
(mo.)* 
1 M 7 26 3 5 Bulbar 37 
2 F 8 29 0 9 Bulbar 22 
3 M 2 24 11 6 Spinal 62 
4 F 3 32 9 10 Bulbar 34 
5 M 7 24 7 7 Bulbar 38 
6 M 2 30 12 7 Spinal 24 
7 F 2 22 7 6 Bulbar 26 
8 M 1 20 10 9 Spinal 91 
9 M 7 39 8 9 Bulbar 36 
10 F 2 26 9 8 Spinal 17 
 
 
Table 5.2 ALS participants respiratory function including forced expiratory volume (FEV1), 
forced vital capacity (FVC), FEV1/FVC, and peak expiratory flow as measured by a hand held 
analog peak flow meter. *Average peak flow as calculated from three voluntary cough trials.  
 
Participant 
ID 
PAS 
Score 
Gender 
Predicted (%) 
FEV1    FVC     FEV1/FVC 
 
 
PEF Average* 
(hand held 
meter) 
L/m 
1 7 M 26 54 48 213 
2 8 F 39 57 76 200 
3 2 M 53 43 126 143 
4 3 F 96 106 99 200 
5 7 M 70 65 110 283 
6 2 M 41 38 109 193 
7 2 F 68 69 109 146 
8 1 M 32 29 115 163 
9 7 M 102 100 107 146 
10 2 F 70 68 108 233 
 
 
 
 
 
 99 
 
Voluntary Cough Airflow in Patients with ALS 
The modified barium swallow study identified 5 safe swallowers (PAS < 2) and 5 unsafe 
swallowers (PAS > 2) within the ALS participant sample.  
Cough Airflow Data 
Based on cough airflow data, no significant differences were revealed between airway 
safety groups for average cough airflow characteristics. There was a significant difference between 
compression phase duration (CPD) for epoch 1, cough 1 between airway safety groups (U = 8, p 
= 0.032). The unsafe swallowing group exhibited a slightly longer compression phase duration 
than the unsafe swallowing group. The air-flow characteristics inspiratory phase duration, 
expiratory rise time, peak expiratory flow, and cough volume acceleration were not significantly 
different between the safe and unsafe groups.  
Anthropomorphic Features of Cough  
 Anthropomorphic acoustic cough features were analyzed based on acoustic cough 
waveforms collected without coupled airflow data. Healthy controls (n = 10) and ALS participants 
(n = 10) were compared. Significant differences were detected between healthy controls and 
patients with ALS for continuous cough phase time (U = 69, p = 0.02). In healthy participants, the 
mean continuous phase length was longer than individuals with ALS (12.4 ms vs. 8.6 ms). No 
other anthropomorphic features such as expulsive phase time, variable phase time, or expulsive 
phase peak amplitude were significantly different between healthy controls and ALS participants.  
Additional analysis was performed to determine if there were differences in 
anthropomorphic features between safe and unsafe swallowers. There were significant differences 
identified for expulsion phase time (U = 2, p = 0.03). The unsafe swallowing group exhibited 
longer expulsive phase time (M = 3.4 seconds +/- 4.7) than the unsafe swallowers (M = 7.60 
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seconds, +/- 4.7). Although the measure of total acoustic cough length did not meet the 0.05 
significance criteria, total cough length was found to be longer in unsafe swallowers (M = 7.4 ms) 
compared to safe swallowers (M = 3.6 ms) (U = 3, p = 0.056). No differences were determined for 
group means for the variable or continuous phases or peak expulsive amplitude.  
Further analysis was performed between ALS participants; in this analysis, groups were 
stratified based on aspiration status. PAS > 6 versus safe swallowers with penetrators were 
compared. In participants who aspirated, there was a significant difference in total cough duration, 
(U = 0, p = 0.01). Total cough length was longer in participants who aspirated (M = 0.99 ms) 
versus those who did not (M = 0.36 ms). Significant difference between mean expulsive phase rise 
time was identified between groups (U = 0, p = 0.01. The expulsive phase time was longer in 
individuals who aspirated (M = 0.3 ms) verses those who did not (M = 0.02 ms).  There was also 
a significant difference for the measure, variable phase time between groups (U = 1, p = 0.01). The 
mean variable phase time was longer in the aspiration group (M = 0.42 ms) versus the non-
aspiration group (M = 0.18). Lastly, peak expulsive phase amplitude was lower in participants who 
aspirated versus those who did not (U = 1, p = 0.01). Mean amplitude for the aspiration group = 
117.7 mV and the non-aspiration group mean amplitude = 318.5 mV. 
Augmenting and decrementing cough pattern  
Based on the cough acoustic waveform signal patterns collected independently from 
airflow signals results showed that all healthy controls (10/10 or 100%) presented with fast onset 
cough pattern. Of the ten ALS participants, seven participants displayed a fast cough onset, and of 
those 7 individuals, all were safe swallowers who did not aspirate. No healthy controls exhibited 
a slow augmenting acoustic cough pattern whereas 40% (4/10) of ALS participants had a slow 
augmenting cough pattern. Four of ten healthy individuals presented with a slow decrementing 
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cough pattern and 7 of 10 ALS participants presented with a slow decrementing cough pattern.  
 
Figure 5.4 Depicted in three panels, A., B., and C. are airflow, acoustic, and spectral 
representations of cough in safe (PAS < 2) and unsafe (PAS > 3) swallowers. Figure 5.4 panel 
B. depicts a fast augmenting and fast decrementing cough pattern found in a safe swallowers 
and a slow augmenting slow decrementing cough pattern as found and unsafe swallower. 
 
Discussion 
 This is the first study to evaluate anthropomorphic features of cough in healthy controls 
and ALS participants. The results of this study showed that there are salient features of acoustic 
voluntary cough signals that are different when comparing aspirators to non-aspirators. However, 
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no significant differences were found between anthropomorphic features of cough in healthy 
controls and ALS participants, or voluntary airflow measures between safe and unsafe ALS 
participants. This data does not confirm what has been previously published (Plowman, Watts, 
Robison, Tabor, Dion, Gaziano, Vu, & Gooch, 2016), and may be due to our small sample size.   
 The present study included a mixed sample of both spinal and bulbar onset ALS in the 
advanced stages of the disease, and thus, both bulbar and spinal features were present in all 
participants. Not surprising, the unsafe group had patients of both bulbar and spinal onset, 
reflecting a global degeneration of cardinal motor symptoms and corticobulbar degeneration. It is 
likely that insidious motor dysfunction across the neural axis contributed to these findings as 
lesions anywhere along the neuraxis may impact cough motor and subsequently acoustic function.  
Physiological impairment leading to dystussia may have origins in airway afferent 
impairment, respiratory muscle weakness, or a combination of both. In terms of motor impairment, 
chest wall rigidity in patients with PD decreases their ability to inflate the lungs (Pitts, 2008). The 
work of Ebihara and colleagues (2003) indicated that involvement of motor and sensory 
impairment might depend on the stage of PD progression. In contrast, the ALS patient population 
presents in a heterogeneous manner and it is difficult to evaluate and benchmark impairment 
especially using clinical indices such as perception via rating scales and even with more objective 
measures. Results suggest that the cough and swallow relationship in ALS may be a much less 
linear relationship between the physiologic parameters as has previously postulated. These results 
may also be reflective of a small sample size.  
Voluntary cough sound patterns have been shown to detect abnormality in pulmonary lung 
function in human models (Abaza, 2009). Abaza and colleagues (2009) investigated simultaneous 
voluntary cough airflow and sound pressure waves (time in seconds over amplitude) using a high 
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fidelity recording system composed of a mouthpiece attached to a metal tube with a microphone. 
The participants (52 health adults and 60 individuals with lung disorders, both male and female) 
watched a short video on how to perform a voluntary cough test. They then were instructed to, 
“keep their glottis open” as they, “coughed vigorously” (Abaza, p. 2) in order to prevent sound 
due to glottal closure. Authors used novel methodology to classify cough sound and airflow 
patterns. They reported that this methodology yielded a 94% rate of identifying abnormal lung 
function in female subjects and 97% rate for identifying abnormal lung function in male subjects.  
As professionals, speech language pathologists have evaluated voice quality in both 
subjective (often with visual analog scales) and objective (vocal acoustic signal) manners as well 
as with models that invoke auditory-processing front-ends to capture the non-linear transformation 
of sound into perceptual constructs (Eddins, 2016; Shrivastav, 2011, 2003). Specifically, there 
have been robust studies of acoustic parameters of subjective quality in voice. However, subjective 
ratings of breathy voice quality have been found unreliable (Kreiman et al., 1993, Dejonckere, 
Obbens, De Moor, Wieneke, 1993) in some studies while very reliable in other studies (Bassich & 
Ludlow, 1986). Thus acoustic measures are often used provide objective quantification of voice 
quality (Bhuta, 2004). However, there is a clear disconnect between acoustic and perceptual 
indices of voice due to the non-linear nature of the perception of sound. Thus, it is not surprising 
that perceptual and acoustic correlates of voice quality are often in poor agreement. Cough creates 
a distinct sound pattern during the transition from a compression phase, or closure of the glottis, 
to expiration is completed (Korpas, 1996). Given the presence of a perceptual sound pattern, it is 
assumed that there are also unique acoustic characteristics that determine and aberrant cough. 
Additionally, Laciuga et al. (2016) identified that physiologic characteristics are associated with 
certain perceptual aspects of cough. Nevertheless, assessment of perceptual strength and 
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effectiveness of cough was less consistent using ratings such as scales and the authors suggested 
that there should be a more uniform way of judging the perceptual attributes of cough (Laciuga, 
Brandimore, Troche, & Hegland, 2016). 
Our study revealed swallowing safety group differences for cough airflow measurements 
but did reveal group-dependent differences in measures within the acoustic cough signal. 
Additionally, when comparing aspirators to non-aspirators, there were multiple differences in 
anthropomorphic cough features. This disparity in results may represent that laryngeal structures 
participating the production of cough and resulting the cough sound pattern are a salient feature of 
cough impairment. The structure of the laryngeal and pharynx responsible for the sound of a cough 
may be an important feature of aberrant cough to investigate beyond cough airflow data.  
Limitations and Future Directions  
 One limitation of the current study is that, the data were recorded and analyzed by the same 
researcher. This presents a potential confound as the results may be analyzed and interpreted with 
bias.  A second limitation is that the study represented a small sample of patients. Finally, the 
analyses were somewhat simplistic. Future work should include a more sophisticated set of 
analyses, blind analyses, and a larger group of samples 
Conclusions 
 The aim of this study was to determine anthropomorphic characteristics of voluntary 
cough acoustic signals in individuals with ALS and healthy controls. We hypothesized that there 
would be anthropomorphic differences between healthy controls and patients with ALS and 
between patients with ALS who are safe swallowers and those who are not safe swallowers. Our 
results did partially supported hypothesis. Significant differences in the continuous cough phase 
were identified; healthy participants demonstrated longer continuous cough phase times than 
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individuals with ALS. This may reflect ability to reach peak flows.  
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CHAPTER SIX  
 
CONCLUSIONS AND FUTURE DIRECTIONS 
 
Results from the studies reported in this dissertation represent several additions to the current 
literature on cough and swallowing. There are well-established relationships between cough and 
swallowing in clinical populations. The relevance of such work is paramount for professionals 
who serve populations with impaired swallow ability as traditional methods of clinical swallowing 
assessment often fail to identify those with impaired swallowing who silently aspirate (i.e., no 
reflexive cough). In addition, dystussia promotes poor airway protection and must be a target of 
evaluation and intervention. Review of current literature indicates that there are several novel 
testing options for cough evaluation within both the voluntary and reflexive methodologies. 
However, these are not readily available for clinical use and have varied measures of sensitivity 
and specificity, which are not suitable for clinical use (Watts, Tabor & Plowman, 2016). 
Additionally, current binary subjective measures (i.e., strong/weak) used during clinical swallow 
assessments fail to provide quantitative data or describe deviant auditory features of cough.  
Cough evaluation within the clinical setting is gaining attention. The survey study 
completed by 605 participants’ revealed that a majority of individuals across practice settings, 
levels of experience, and certification are assessing coughing in their clinical practice. The measure 
of “strength” is used most constantly. However, strength is a continuum of performance and not a 
binary outcome. With a growing body of basic and clinical literature demonstrating strong 
relationships between swallowing and airway protective behaviors; there is an urgent need for 
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standardization of cough assessment protocols and terminology.  
Although there are studies that focus on the relationship between cough and swallow, there 
is a paucity of data on clinician reliability of assessing cough function, or deviant audible features 
of dystussia which may inform clinicians of decreased airway protection. The third study 
investigated perceptual ratings of cough using a visual analog scale (VAS) and defined binary 
ratings of aberrant cough. The study showed promising results for revealing differences between 
airway safety groups for perceptual measures of effectiveness and binary measures of “huffing”. 
However, in line with literature concerning the use of VAS scales in perceptual analysis, the 
measures were largely unreliable between different raters.  
The fourth study aimed to investigate a novel method of cough evaluation for the purpose 
of identifying safe versus unsafe swallowers and differentiating cough patterns between healthy 
controls and ALS participants. Differences in anthropomorphic features of cough based on 
(airflow, acoustics, both?) between aspirators and non-aspirators indicate that there are salient 
features between airway safety groups that differ and may help identify those at risk for aspiration. 
Unfortunately, the evaluation method failed to differentiate healthy controls versus ALS 
participants suggesting this methodology may not yield favorable sensitivity and specificity 
results.  
The systematic studies presented inherent limitations such as having non-standardized 
acoustic recordings of cough for VAS analysis, non-standardization of blinding methods for 
anthropomorphic analysis, and small number of participants. However, given several significant 
findings across the body of work, further investigation is required in order to continue to identify 
salient features of aberrant cough that differentiate patients who are at risk for poor airway 
protection and potentially help decrease morbidity and mortality due to pulmonary injury. 
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APPENDIX B: 
SURVEY IRB 
 
 
June 5, 2015 
Stephanie Watts (Randall) 
Communication Sciences and Disorders 
Tampa, FL  33604 
 
RE: Exempt Certification 
IRB#: Pro00017474 
Title: Survey of Clinical Swallow Evaluation 
 Practices  
 
Dear Ms. Watts (Randall): 
On 6/5/2015, the Institutional Review Board (IRB) determined that your research meets criteria 
for exemption from the federal regulations as outlined by 45CFR46.101(b): 
(2) Research involving the use of educational tests (cognitive, diagnostic, aptitude, 
achievement), survey procedures, interview procedures or observation of public behavior, 
unless: 
(i) Information obtained is recorded in such a manner that human subjects can be identified, 
directly or through identifiers linked to the subjects; and (ii) any disclosure of the human 
subjects' responses outside the research could reasonably place the subjects at risk of 
criminal or civil liability or be damaging to the subjects' financial standing, employability, or 
reputation. 
 Approved Items: 
Protocol_5.22.15 
Informed Consent 
As the principal investigator for this study, it is your responsibility to ensure that this research 
is conducted as outlined in your application and consistent with the ethical principles outlined 
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in the Belmont Report and with USF IRB policies and procedures. 
Please note, as per USF IRB Policy 303, "Once the Exempt determination is made, the 
application is closed in eIRB. Any proposed or anticipated changes to the study design that 
was previously declared exempt from IRB review must be submitted to the IRB as a new 
study prior to initiation of the change." 
If alterations are made to the study design that change the review category from Exempt (i.e., 
adding a focus group, access to identifying information, adding a vulnerable population, or an 
intervention), these changes require a new application. However, administrative changes, 
including changes in research personnel, do not warrant an amendment or new application. 
Given the determination of exemption, this application is being closed in ARC. This does not 
limit your ability to conduct your research project. Again, your research may continue as 
planned; only a change in the study design that would affect the exempt determination requires 
a new submission to the IRB. 
 
We appreciate your dedication to the ethical conduct of human subject research at the 
University of South Florida and your continued commitment to human research protections. If 
you have any questions regarding this matter, please call 813-974-5638. 
 
Sincerely, 
 
Kristen Salomon, Ph.D.,  
Vice Chairperson USF Institutional 
Review Board 
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APPENDIX C: 
 
SURVEY OF CLINICAL SWALLOW EVALUATION PRACTICES 
 
*Mandatory questions are denoted with an asterisk 
 *1) Are you a Speech Language Pathologist (SLP) or SLP student? 
1. Yes  
2. No 
 
2) What is your professional title? 
1. Medical Doctor (MD) 
2. Registered Nurse (RN) 
3. Licensed Practical Nurse (LPN) 
4. Other: Please type in title: 
 
3) What is your speech language certification? Please select all that apply. 
1. Ph.D. 
2. BRS-S 
3. CCC-SLP 
4. CF-SLP 
5. SLPA 
6. Student 
 
*4) Years of experience in medical SLP practice. 
1. <1 year 
2. 1-2 years  
3. 3-5 years 
4. 6-10 years  
5. 11-20 years 
6. 20 + years 
 
*5) Country where you practice 
1. United States 
 139 
 
2. Canada  
3. None of the above 
 
 
*6) State where you practice  
1-50. Select drop down of U.S. states 
*7) Which type of facility do you work in? Pick all that apply. 
1. Skilled nursing facility (SNF) 
2. Hospital  
3. Private practice 
4. Voice center 
5. Swallow center 
6. Voice and swallow center 
7. University medical clinic 
8. SLP graduate training clinic 
9. Outpatient rehabilitation 
10. Other 
 
*8) Please select all that apply in regards to your main caseload. 
1. Outpatient rehabilitation 
2. Inpatient rehabilitation 
3. Acute 
4. Sub-acute 
5. ICU 
6. SICU 
7. Other 
 
*9) Do you conduct clinical (bedside) swallow examinations? 
1. Yes 
2. No 
 
*10) What populations do you assess with a clinical swallow evaluation? Select all that 
apply. 
 
1. Neurogenic 
2. Head and Neck 
3. Trauma 
4. Cardiac Care 
5. Long-term care 
6. Post surgical 
7. Other 
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11) Why do you not perform clinical swallow evaluations? Select all that apply. 
1. I am not trained in conducting clinical swallow evaluations 
2. I only perform instrumental examinations 
3. Clinical swallow does not provide adequate diagnostic information 
4. In none of the above, please provide other reason(s) 
 
*12) Do you perform an oral mechanism examination during your clinical swallow      
evaluation? 
 
1. Yes 
2. No 
 
*13) Do you assess voluntary cough (e.g., ask the patient to preform a cough)? 
1. Yes 
2. No 
 
*14. What aspects of voluntary cough do you listen for to indicate abnormality (e.g.,        
strength)? 
 
1. Open typed response 
*15). Please list all of the components of you clinical swallowing evaluation. 
1. Open typed response 
*16) Please select the validated swallow protocols you are familiar with (you may select 
more than one). 
 
1. Yale 3 oz. water swallow test 
2. The Toronto Bedside Swallow Screening Test (TOR-BSST) 
3. Gugging Swallowing Screen 
4. Modified Mann Assessment of Swallowing Ability (MMASA) 
5. Other 
 
*17) Of the previous validated swallow protocols you selected, do you implement and of 
these in clinical practice? 
 
1. Yes 
2. No 
 
18) If you do not implement validated clinical swallow protocols, please briefly indicate    
why. 1. Open typed response 
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APPENDIX D: 
PERCEPTUAL AND PHYSIOLOGIC COUGH ASSESSMENT IRB 
 
 
 
 
 
10/5/2015 
Stephanie Watts (Randall) 
Communication Sciences and Disorders 
1017 E Crenshaw Street 
Tampa, FL 33604 
 
RE: Full Board Approval for Initial Review 
IRB#: Pro00023151 
Title: Perceptual and Physiologic Analysis of Dystussia for the Assessment of Dysphagia 
 
STUDY APPROVAL PERIOD: 10/5/2015 TO 10/5/2016 
Dear Ms. Watts: 
On 10/5/2015, the Institutional Review Board (IRB) reviewed and APPROVED the above 
application and all documents contained within, including those outlined below. 
Approved Item(s): 
Protocol 
Document(s):  
Protocol V2 CLEAN 
 
CONSENT/ASSENT DOCUMENT(S)*: 
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Dystussia ICF V3 CLEAN.pdf 
 
*Please use only the official IRB stamped informed consent/assent document(s) found under 
the "Attachments" tab. Please note, these consent/assent document(s) are only valid during the 
approval period indicated at the top of the form(s). 
 
As the principal investigator of this study, it is your responsibility to conduct this study in 
accordance with IRB policies and procedures and as approved by the IRB. Any changes to the 
approved research must be submitted to the IRB for review and approval via an amendment. 
Additionally, all unanticipated problems must be reported to the USF IRB within five (5) 
calendar days. 
 
We appreciate your dedication to the ethical conduct of human subject research at the 
University of South Florida and your continued commitment to human research protections.  
If you have any questions regarding this matter, please call 813-974-5638. 
 
Sincerely, 
 
E. Verena Jorgensen, M.D., Chairperson 
USF Institutional Review Board 
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APPENDIX E: 
 
MATLAB CODING 
 
%run data analysis 
clear all; clc; close all; 
rootdir = pwd; 
addpath(genpath(rootdir)); 
[filename,path] = uigetfile(); 
data.fullname = fullfile(path,filename); 
data.filepath = path; 
data.filename = filename; 
 
[alldata,time] = importData(data.fullname); 
 
chansegexp = inputdlg({'Enter Channel Number','Enter Segment Number','Enter Master File for Export'},'Select 
Data',1,{'2','4','masterfile.xlsx'}); 
chan = str2double(chansegexp{1}); 
seg = str2double(chansegexp{2}); 
data.exportFN = chansegexp{3}; 
 
data.x = time{chan,seg}'; 
data.y = alldata{chan,seg}; 
data.finish = 0; 
%begin analysis of this file 
 
idx = 1;  %keep track all files/segments 
 
%get data points 
while ~data.finish     
    [handles.brushPage,data] = brushPage(data); 
    %set(handles.brushPage,'Visible','off'); 
     
    [handles.analysisPage,data] = analysisPage(data); 
   % set(handles.analysisPage,'Visible','off'); 
     
    allData{idx} = data; 
    idx = idx + 1; 
end 
 
 
 
%calculate all derived measures 
for ii = 1:length(allData)     
 144 
 
    %IPD (B-A) in time 
    allData{ii}.IPD = allData{ii}.B(1)-allData{ii}.A(1); 
     
    %IPFF (E) 
    allData{ii}.IPPF = allData{ii}.E(2); 
     
    %CPD (C-B) in time 
    allData{ii}.CPD = allData{ii}.C(1)-allData{ii}.B(1); 
    
    %EPRT (D-C) in time 
    allData{ii}.EPRT = allData{ii}.D(1)-allData{ii}.C(1); 
     
    %EP (D - C) in amplitude 
    allData{ii}.EP = allData{ii}.D(2) - allData{ii}.C(2); 
     
    %CVA (D/(D-C)) in ampliude/time 
    allData{ii}.CVA = allData{ii}.EP/allData{ii}.EPRT; 
end 
 
 
[pth,name,ext] = fileparts(data.filename); 
datafile = fullfile(rootdir,'export',[name,'_export',ext]); 
%save to files 
save(datafile,'allData');  %mat file 
 
exportData(allData);  %xlsx file 
 
